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ABSTRACT PAGE
Teleosts, including rainbow trout, provide an important animal model for immune system  
function a s  they lack bone marrow, but utilize the anterior kidney a s  their primary site for 
hematopoiesis. The activation, proliferation, and differentiation s tag es  of trout B cells and 
the location of th ese  p rocesses within the immune tissues are  not well defined. Expression 
patterns of B cell transcription factors can be used a s  m arkers to investigate the B cell 
stages. In this study, the transcription factors Pax-5 and Xbp-1, a s  well a s  RAG-1, 
M embrane IgM, Secreted  IgM, Total IgM, and BrdU incorporation w ere used a s  m arkers in 
trout B cells. Pax-5 is expressed  from pre-B through plasm ablast stages, while Xbp-1 
expression increases after B cell activation and is highest in plasm a cells. RAG-1 is 
expressed  in pro- and pre-B cells and activated B cells/plasm ablasts during Ig gene 
rearrangem ent. BrdU incorporation is a m arker for B cell proliferation and is seen  in pre-B 
cells and plasm ablasts. M em brane IgM is found on the cell surface from the resting B cell 
through plasm ablast stages, while Secreted IgM is produced by plasm ablasts and plasm a 
cells. The expression patterns of these  markers, when analyzed by flow cytometry, provide 
information about the B cell populations present in trout immune tissues. Trout immune 
cells from the spleen, blood, anterior and posterior kidney w ere LPS-activated in culture, 
fixed and permeabilized, and stained cells w ere analyzed by two-color flow cytometry. The 
results presented here suggest that the anterior kidney contains mostly developing B cells, 
a s  very few LPS-responsive m ature B cells w ere seen  through the lack of an increase in 
Xbp-1 or Total or Secreted  IgM expression. In contrast to the anterior kidney, the spleen, 
blood, and posterior kidney were found to contain populations of resting B cells that 
becom e activated following LPS-stimulation. In addition, Xbp-1 can be used a s  a m arker 
for B cell activation in th ese  tissues. In spleen and blood B cells, Xbp-1 expression 
increases after activation, correlating with progression from the resting to activated B cell 
stage  and eventual differentiation into plasm ablasts and plasm a cells. Lastly, BrdU proved 
a  successful m arker for B cell proliferation. Proliferating B cells were found in the spleen, 
anterior and posterior kidney, while no proliferation w as detected  in the blood. This study, 
for the first time, analyzed B cell responses to antigenic stimulation ex vivo a s  defined by 
the frequencies of the resting B, activated B, plasm ablast, and plasm a cell populations in 
the rainbow trout. As additional B cell m arkers a re  tested, future studies can provide further 
information about the complex B cell populations presen t in the immune tissues of the 
rainbow trout and other teleosts.
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CHAPTER I
Literature Review
The immune system defends the body against invading pathogens such as 
bacteria, viruses, and fungi. Specialized cells make up the immune system and one of 
these is the B cell. The B cell is a unique cell that has a receptor on its membrane that is 
antigen-specific, the B Cell Receptor (BCR). When the BCR comes into contact with and 
binds to its specified antigen, the B cell becomes activated, proliferates, and differentiates 
into a plasma cell that secretes antibodies known as immunoglobulins (Ig). The secreted 
immunoglobulins recognize the same antigens as the BCR and travel throughout the 
body, clearing the infection.
1.1. The Mammalian Immune System
1.1.1. Lymphopoiesis and B cell development
In the immune system, there are two types of immune tissues: the primary and the 
secondary. The primary immune tissues are sites of cell development and maturation, 
while the secondary immune tissues are sites of antigen encounter and response. In the 
mammalian immune system, the bone marrow serves as the primary immune organ, 
providing a sterile environment for B cell development and maturation. The lymph nodes, 
spleen, and mucosa-associated lymphoid tissues (MALT) are the secondary immune
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tissues where B cells interact with antigen, proliferate, and differentiate into 
immunoglobulin-secreting plasma cells.
The hematopoietic stem cell (HSC) gives rise to all of the cells of the immune 
system. HSCs are self-renewing, pluripotent cells that reside in the bone marrow of 
mammals [49, 105]. Depending on the environment and growth factors available, HSCs 
can follow either the lymphoid or myeloid developmental pathway. HSCs differentiate 
into either the common lymphoid progenitor (CLP) or the common myeloid progenitor 
(CMP). The CLPs give rise to B and T cell progenitors or Natural Killer cells and the 
CMPs give rise to progenitors that eventually differentiate into macrophages, 
granulocytes (basophils, eosinophils, or neutrophils), platelets, erythrocytes (red blood 
cells), or dendritic cells [49]. B cell specific transcription factors and environmental cues 
will lead a CLP to B cell lineage commitment.
B cell development and maturation progresses through a series of successful site- 
specific Ig gene rearrangements (Figure 1 [9]). The immunoglobulin protein is made up 
of two heavy chains (HC) and two light chains (LC). The Ig HC and LC genes are 
comprised of variable (V), diversity (D), and joining (J) segments, which rearrange and 
combine with one another to form a functional Ig gene. The HC gene is made up of V, D, 
and J segments and the LC gene is made up of V and J segments (reviewed in [86]). The 
recombinases encoded by the Recombination Activating Genes-1 and -2 (RAG-1 and 
RAG-2) are required for the recombination of the V(D)J gene segments in the Ig genes. 
RAG-1 and RAG-2 are present in early B and T cells, where they initiate recombination
2
of the B cell receptor (BCR) HC and LC genes and the T cell receptor (TCR) genes, 
respectively. The RAG-1/2 complex initiates V(D)J recombination by recognizing, 
binding, and cleaving the DNA at specific sites known as recombination signal sequences 
(RSS). A double strand DNA break is formed by the RAG complex at the RSSs, 
initiating V(D)J recombination. The V(D)J segments are joined and the DNA is repaired, 
forming a complete Ig heavy chain or light chain gene [43, 74]. The RAG complex has 
not been found in non-lymphoid cell lines or tissues [67, 87]. However, CLPs have been 
shown to undergo D-J recombination on the HC locus, but retain their ability to 
differentiate into T cell progenitors [8].
Bone M arrow
Lymphoid
Progenitor
Early Pro-B 
Cell
Late Pro-B 
Cell
Pre-B Cell
pre-BCR
Immature 
B Cell
BCR
D-J
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Figure 1. B cell development and maturation in the mammalian immune system. The
development o f B cells from the earliest, uncommitted lymphoid progenitor cells to the terminally 
differentiated plasma cells. The stages o f V(D)J recombination are indicated.
Progenitor B (pro-B) cells are the earliest distinctive cells of the B cell linage 
(Figure 1). These cells develop in the bone marrow, an environment that provides the 
stromal cells necessary for their development and survival. Stromal cells provide the
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growth factors and cytokines, such as IL-7, necessary to maintain the pro-B cells during 
this stage of development [33].
The first step in the Ig gene rearrangement occurs in the pro-B cell where the Ig 
HC gene is rearranged. The D and J segments are joined first, followed by the joining of 
the V segment to the D-J segment. Each HC gene has multiple V, D, and J segments that 
are randomly chosen for rearrangement, creating diversity in immunoglobulin specificity. 
The HC genes are located on both chromosomes in the cell. However, due to the process 
of allelic exclusion, only one HC allele undergoes recombination to produce the Ig HC 
protein [33, 69]. After VDJ recombination in the pro-B cells, the Cg gene segment, 
encoding IgM constant region, is joined to the immunoglobulin HC gene. The constant 
(C) segment determines the isoform of the immunoglobulin. Mammals have five different 
Ig isoforms: IgM, IgD, IgG, IgE, and IgA encoded by the Cg, C8, Cy, Cs, and Ca gene 
segments. In pro-B cells, Cg is the only C segment capable of joining with the VDJ 
segment, thus producing a p HC gene. RNA polymerase II transcribes the p HC gene 
and this leads to the production of the p protein [46, 47].
After successful production of the p HC protein, the pre-BCR is assembled on the 
surface of pro-B cells (Figure 2). The pre-BCR consists of the rearranged p HC, the 
Iga/Igj3 heterodimer, and the surrogate LC, composed of the Vpre-B and the 7,5 proteins 
[74]. The pre-BCR is an important checkpoint in early B cell development. Signaling 
through the pre-BCR promotes allelic exclusion, alerting the cell that the first Ig heavy 
chain locus has undergone successful V D J recombination and preventing the second Ig
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heavy chain locus from being processed [7, 46, 74]. The expression of the p membrane Ig 
heavy chain protein is necessary for the progression of B cells beyond the pro-B cell 
stage [47]. The pre-BCR also signals a decrease in RAG-1 expression [29] and stimulates 
cell proliferation and differentiation of pre-B cells [74, 79].
Experiments done in pro-B cells with the loss of Iga, Igp, or the entire complex 
show that Iga and Igp are not required for VDJ recombination of the Ig heavy chain 
gene. However, pro-B cells lacking one or both parts of the Iga/Igp complex were 
arrested at the pro-B cell stage, showing that the signaling from the Iga/Igp complex is 
necessary for the pro-B cells to proliferate and differentiate to pre-B cells [71].
Pre-B Cell Receptor B Cell Receptor
Iga/ IgP Heterodimer
Pro-B Cell Pre-B Cell Im m ature B Cell
Figure 2. The B cell receptor (BCR). The stages of B Cell Receptor (BCR) formation are seen in Figure 
2. The pro-B cell is seen on the left with the formation o f the Iga/IgP (CD79a/CD79b) signaling complex. 
The pre-B cell is seen in the center o f the figure. The two IgM heavy chain proteins are seen connected to 
each other and to the surrogate light chains by disulfide bonds. The two surrogate light chains are made up 
o f the Vpre-B and the A.5 proteins. The Iga/IgP complex is seen flanking the C region o f the heavy chains. 
The long tails o f the Iga/IgP complex extend from the cell membrane to the inside o f the cell and act as the 
signal transducers o f the pre-BCR and BCR. The immature, resting B cell is seen on the right. The 
surrogate LC has been replaced by either the k  or X LC.
Pre-B cells are also contained within the nutrient-rich environment of the bone 
marrow, but they do not require interaction with stromal cells for their growth and
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survival [33, 99]. Rearrangement of the light chain gene occurs at this stage of B cell 
development. The light chain gene is comprised of only V and J segments, and RAG-1 
and RAG-2 are expressed in pre-B cells to allow for the V-J recombination to occur as it 
did in the pro-B cells [67, 87]. RNA polymerase II transcribes the rearranged light chain 
gene. Successful rearrangement of the light chain gene leads to the differentiation of the 
pre-B cells to immature, resting B cells.
The rearranged V(D)J gene segments make up the variable region of the 
immunoglobulin heavy chain and light chain proteins. The variable region is the site of 
antigen recognition and is specific to one antigen. The constant region of the 
immunoglobulin comes from the HC and provides the structure and signaling for the 
immunoglobulin, as well as the Ig isoform and effector activities. As mentioned 
previously, mammals have five different Ig isoforms encoded by the five different C gene 
segments. The constant region is assembled through RNA splicing of the C segment to 
the rearranged heavy chain gene and alternative splicing leads to the production of the 
different Ig isotypes: IgM, IgD, IgG, IgE, and IgA (reviewed [86]).
Resting, immature B cells possess complete BCRs on their surface. The BCR is 
comprised of the complete IgM protein, including the HC and LC proteins, and the 
Iga/Igp heterodimer. The Iga/Igp heterodimer communicates with the surface IgM when 
antigen is bound. The Iga/IgP heterodimer has a longer amino acid tail than the IgM 
protein and is responsible for signaling to the B cell that antigen has been bound, setting 
off the signaling cascade that leads to B cell activation [38]. Each B cell possesses
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multiple BCRs on its surface. The binding site on each BCR is specific for one antigen, 
and all BCRs on the B cell are specific for the same antigen. While the resting B cells are 
in the bone marrow, they are not exposed to foreign antigen. If the BCR does interact 
with antigen in this environment, it would be self-antigen and negative selection would 
occur. The B cell and/or the BCR would be eliminated [45].
1.1.2. B cell activation, proliferation, and differentiation
Resting B cells travel to the peripheral lymphoid organs, such as the spleen or 
lymph nodes, by way of the blood or lymph fluid. Once in the periphery, the B cell is 
considered a mature, resting B cell. Mature, resting B cells have both membrane-bound 
IgM and IgD on their surface due to a change in the RNA processing that allows for the 
production of a chimeric molecule containing the Cp and C6 segments. IgD is a surface 
marker for mature, resting B cells, but it is never present in the secreted form and its 
function is unknown. The membrane IgM and IgD proteins on a B cell have the same 
antigenic specificity, but different effector activities. If the B cell encounters its specific 
antigen, the BCRs on its surface will bind the antigen and cross-link with one another. 
The cross-linking of the BCRs sets off a signaling cascade, activating the B cell and 
beginning the steps towards plasma cell differentiation (Figure 3).
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Figure 3. B cell activation, proliferation, and differentiation in the mammalian immune system. This 
figure shows the maturation o f B cells from the resting stage to the Ig-secreting plasma cell stage. 
Membrane-bound immunoglobulin is seen on the surface o f resting B, activated B, and plasmablasts while 
Ig is secreted by plasmablasts and plasma cells. The plasmablast can differentiate into a memory B cell or a 
plasma cell.
Recognition and binding of the antigen by the BCRs initiates differentiation to 
plasmablasts and cell proliferation. Plasmablasts are larger than activated B cells as they 
increase in size before they divide. B cell proliferation at this stage creates clones that 
have the same antigenic specificity, thus creating a large number of B cells that recognize 
the invading antigen.
Recently, antibody-secreting cells (ASCs) have been defined in the mammalian 
immune system as plasmablasts (PB), short-lived plasma cells (SL), long-lived plasma 
cells (LL), and B-l B cells (see below). Plasmablasts, as described above, are B cells that
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proliferate and produce both membrane and secreted IgM and plasma cells are non­
dividing, Ig secreting cells [56, 66, 97, 98].
As plasmablasts proliferate, they can differentiate into plasma cells or memory B 
cells. Plasma cells have no membrane-bound immunoglobulin and they do not 
proliferate. They are the effector cells of the B cell lineage, secreting immunoglobulins 
into the cytoplasm to travel throughout the body and remove antigen. The 
immunoglobulins secreted by plasma cells have the same antigenic specificity as the 
membrane-bound immunoglobulin of the earlier B cell stages [11].
Some plasmablasts rapidly proliferate upon antigenic stimulation and differentiate 
into SL plasma cells in the secondary lymphoid organs. These plasma cells survive for a 
few weeks, producing antibody to fight off the invading antigen [66]. Other plasmablasts 
proliferate and differentiate into LL plasma cells. LL plasma cells home back to the bone 
marrow where their life span increases from a few weeks to a few months. The bone 
marrow provides a safe, nutrient-rich environment where LL plasma cells may survive 
and maintain serum antibody levels for months [26, 57, 66].
In contrast to the short life span of plasma cells (SL plasma cells), memory B cells 
may survive for months to years. Memory B cells are produced in the peripheral 
lymphoid organs and may be stored in the lymph nodes or the spleen. Memory B cells do 
not secrete immunoglobulins, but they have membrane-bound immunoglobulin (BCR) of 
the same antigenic specificity as the B cells from which they arose. Upon future
9
stimulation with antigen, memory B cells can become activated and differentiate into Ig- 
secreting cells, thus providing a quicker, stronger response to the antigen [45].
The B cells discussed above have derived from the mammalian adult bone 
marrow and these cells are commonly referred to as B-2 cells. A subset of B cells, known 
as B-l B cells, has recently been characterized. Studies suggest that B-l cells originate in 
the fetal liver and are therefore termed fetal/neonatal B cells. B-l B cells are found in the 
spleen and peritoneal and pleural cavities of mammals. B-l cells express high levels of 
surface IgM and low levels of IgD. They secrete IgM and are believed to be responsible 
for the majority of the natural IgM produced in normal (without antigenic stimulation) 
animals. B-l B cells have a similar phenotype to activated B cells (with the exception of 
a few surface markers) and are important to consider when looking at IgM production in 
peripheral immune organs (reviewed in [5, 34, 36]).
Following B cell activation, the process of class-switch recombination may occur, 
which allows for the production of the other Ig isoforms. Class switch recombination 
occurs through DNA rearrangement where one C gene segment replaces another. This 
allows plasma cells to secrete IgM, IgG, IgE, or IgA. The C segments determine the 
isotype and effector activity of the Ig. The Ig isoforms of a B cell all have the same 
antigenic specificity but different effector functions, giving the immunoglobulins more 
functional diversity (reviewed [86]).
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1.2. The Teleost Immune System
1.2.1. Immune tissues of teleosts
Teleost fishes are members of the Osteichthyes (bony fish) superclass. The teleost 
infraclass contains both marine and freshwater fish, including the rainbow trout 
(Oncorhynchus my kiss), salmon (Salmo salar), zebrafish (Danio rerio), carp (Cyprinus 
carpio), cod (Gadus morhua), halibut (Hippoglossus hippoglossus), and pufferfish 
(Takifugu rubripes), among many others.
When compared to mammals, the anatomy of teleosts is unique in that they lack 
bone marrow and lymph nodes [107]. While the immune system provides comparable 
protection in mammals and teleosts, the timing and location of immune responses in 
teleosts have not yet been characterized, as they have in mammals. In the mammalian 
immune system, the bone marrow is the primary immune organ, while in teleosts, 
including rainbow trout, the anterior region of the kidney serves as the primary site for 
immune cell development and maturation. The spleen, and possibly the blood and 
posterior region of the kidney, serve as secondary immune organs in teleosts, where 
lymphocytes encounter and respond to antigen [93]. Teleost lymphocytes share the same 
basic morphology and structure of mammalian lymphocytes [25].
The trout kidney is located dorsally in the fish, along the ventral surface of the 
vertebral column, above the swim bladder. It is a narrow, bi-lobed (at the anterior end)
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organ that runs nearly the entire length of the trout body, from the braincase to the 
anterior region of the tail. The trout kidney can be separated into three regions, the 
anterior kidney (also called the head kidney or pronephros), the mid-kidney, and the 
posterior kidney. The exact functions of the mid-kidney are not clear at this point, but it 
does appear to contain both immune and renal tissue. The anterior kidney contains 
hematopoietic (immune), endocrine, and reticuloendothelial tissues, while the posterior 
contains mainly renal tissue and some immune tissue, making these regions of the kidney 
interesting in the understanding of the immune system of the trout [68].
The primary function of the anterior kidney is to act as a site for hematopoiesis 
[68, 107]. As a predominantly immune tissue, the anterior kidney is devoid of nephrons 
and has no renal function. The posterior kidney functions primarily in waste elimination, 
filtering the blood for excretion of metabolic waste through urine production [68]. While 
immune cells are in the minority in the posterior kidney, this tissue still provides immune 
function. The Zwollo lab has proposed that the posterior kidney is a secondary immune 
organ where B cells encounter antigen, become activated, and differentiate into plasma 
cells [108].
The spleen filters the blood and serves as a secondary immune site for 
lymphocyte maturation and antigen encounter [25]. The blood is a transport organ, 
bringing antigens and immune cells to the different immune tissues in the body, but we 
hypothesize that it may also contain its own distinct population of B cells and serve as a 
secondary immune tissue.
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1.2.2. Lymphopoiesis and B cell development in teleosts
As a homologous tissue to the mammalian bone marrow, the teleost anterior 
kidney is a hematopoietic tissue and the site of immune cell production. Studies in carp 
{Cyprinus carpio) and zebrafish {Danio rerio) have shown that the teleost anterior 
kidney, much like the mammalian bone marrow, provides the nutrient-rich environment 
necessary for the development and survival of HSCs ([48, 101], respectively).
As in the mammalian bone marrow, HSCs in the teleost anterior kidney are 
believed to differentiate into the cells of the lymphoid and myeloid lineages (described in 
section 1.1.1 in mammals), but this has not yet been elucidated in teleosts. Stromal cells 
in the anterior kidney are believed to secrete the cytokines and growth factors necessary 
for the survival and maintenance of the immune cells. Lineage specific transcription 
factors and cues presumably lead to the development of the specific immune cells, such 
as the B cell. Some evidence for the existence of the earliest B cell progenitors (pro-B 
cells) in the anterior kidney has been documented in zebrafish {Danio rerio) [103] and 
carp {Cyprinus carpio) [40], where RAG-1 and RAG-2 expression were seen in the 
anterior kidney. These studies show that developing B cells exist in the anterior kidney, 
agreeing with the observation that it is the primary immune organ in teleosts. A RAG-1 
mutation in zebrafish showed no V(D)J recombination, no Ig assembly, and no Ig 
secretion, indicating that RAG-1 expression is necessary for V(D)J recombination and Ig 
production in zebrafish, as it is in mammals [103]. Both studies show that developing B
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cells are present in the anterior kidney and V(D)J recombination takes place in the cells 
here.
1.2.3. Teleost immunoglobulin classes
Immunoglobulins are produced by B cells in all jawed vertebrates through the 
process of V(D)J recombination. As mentioned previously, the effector activity of the 
immunoglobulin depends on the C isotype. In mammals, there are 5 isotypes (IgM, IgD, 
IgG, IgA, and IgE) while the number and class of isotypes vary in teleosts. IgM is the 
only isotype that is universal among all vertebrates, but its structure varies among species 
[23]. In both mammals and teleosts the membrane form is generally a monomeric 
structure consisting of two Ig heavy chains and two Ig light chains. The secreted form is 
generally a pentameric structure in mammals, while in teleosts the secreted form is 
generally a tetrameric structure (reviewed in [60]).
It was recently determined that teleosts, like mammals, produce IgD. Studies in 
channel catfish (Ictalurus punctatus) B cells found an Ig heavy chain that was not the 
well-characterized IgM heavy chain. The molecule was chimeric, expressing the p exon 
of the IgM heavy chain and the next downstream exon. This new exon had the same 
characteristics as the mammalian 5 exon of the IgD heavy chain and was co-expressed in 
some, but not all, of the catfish B cells, confirming the existence of a homolog to the 
mammalian IgD in teleosts [104]. This study found separate terminal exons for both 
membrane and secreted forms of IgD, which would differ from the mammalian with no
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IgD secretion. A study in cod (Gadus morhua) found no IgD secretion and found less IgD 
than IgM on B cells [96].
In the rainbow trout (Oncorhynchus mykiss) a third Ig isotype, IgT, was recently 
characterized [32]. The cDNA of a unique isotype was found in trout B cells. The IgT 
gene was found to have its own D and J segments and separate terminal exons for 
membrane and secreted forms. IgT expression was seen in the spleen, anterior and mid­
kidney with a small number of IgT expressing cells seen in the blood. IgM and IgT are 
both found in trout B cells throughout development; however, most B cells are IgM+, 
followed by IgD and then IgT [32]. Due to the lack of antibodies that recognize trout IgD 
and IgT, this study focused on the characterization of B cells that produce IgM.
1.2.4. B cell activation, proliferation, and differentiation in teleosts
A number of flow cytometric studies have been conducted in various teleost 
systems using monoclonal antibodies [21, 30, 41, 48, 59, 70, 72, 83, 84, 95, 96, 109]. In 
these studies, the majority of monoclonal antibodies used have been directed against the 
IgM HC/LC proteins, allowing for the identification of IgM+ B cells in trout 
(Oncorhynchus mykiss) [21, 83, 95, 109], Chinook salmon (Oncorhynchus tshawytscha) 
[59, 72], cod (Gadus morhua) [96], ginbuna carp (Carassius auratus) [48], and halibut 
{Hippoglossus hippoglossus) [30, 70].
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Previous work from the Zwollo lab using flow cytometric analyses of purified B 
cells has shown low to undetectable levels of IgM secretion in freshly isolated spleen and 
blood B cells [109]. After LPS-activation, varying levels of IgM secretion were seen in 
these tissues by Day 7 in culture. In a study using B cells separated by cell density 
gradient centrifugation, the anterior kidney was found to contain the highest number of 
antibody-secreting cells (ASCs), with the majority of these cells most likely representing 
IgM secreting plasma cells. ASCs were found in the anterior and posterior kidney and the 
spleen, while few to no ASCs were found in the blood [108]. The results from these 
studies are in agreement with work done in both salmon [59, 72] and carp [50].
Studies by other groups in the salmon (Salmo salar) have used monoclonal 
antibodies and flow cytometry to look at membrane IgM and secreted IgM ([59, 72], 
respectively). Petterson et al. found plasma cells/ASCs in the spleen, blood, and anterior 
kidney of salmon, with the highest frequency of plasma cells seen in the spleen and very 
few seen in the blood [72]. Plasma cells have also been found in the spleen, blood, and 
anterior kidney of carp (Cyprinus carpio) [50].
Atlantic salmon {Salmo salar) anterior kidney, spleen, and blood cells that were 
LPS-activated and grown in vitro for 10 days, showed B cell activation as well as an 
increase in cell size. The resting B cell populations of the spleen and blood looked similar 
to one another. After LPS activation, the spleen showed an increase in the number of B 
cells and the amount of membrane IgM expression through Day 7. The anterior kidney B 
cell population did not show any change after LPS activation [59].
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Studies done in cod (Gadus morhua) have shown that the anterior kidney, spleen, 
and blood all contain populations of Ig+ B cells. The blood has the lowest proportion of 
B cells relative to total cell number, while the spleen and anterior kidney contain high 
numbers of Ig+ B cells [80]. B cell distribution in immune tissues has been characterized 
in many teleosts based on the expression of membrane and secreted IgM. In studies with 
trout (Oncorhynchus mykiss) [75], cod {Cyprinus carpio) [89, 96], sea bass 
(Dicentrarchus labrax) [84], halibut {Hippoglossus hippoglossus) [70] and puffer fish 
{Takifugu rubripes) [60] B cells were seen scattered throughout the anterior kidney and 
spleen. In these same studies, B cells were also found clustered around blood 
vessels/vascular rich tissue within the anterior kidney and spleen where the cells may 
encounter antigen from the blood.
When characterizing B cell populations in rainbow trout, ASCs were found in the 
kidney, spleen, and blood [8]. Spleen and anterior kidney cells showed an ASC response 
(proliferation and Ig secretion) in the first day of culture in the absence of LPS. LPS- 
activation of these early responding cells repressed the ASC response in both the anterior 
kidney and the spleen, suggesting that previously activated B cells respond differently to 
LPS than developing/resting B cells. The lack of the ASC response may also be due to 
the inability of the activated B cells to respond to LPS ex vivo. Proliferating cells were 
seen in the anterior kidney, spleen, and blood based on 3HT uptake, and addition of 
hydroxyurea (HU), a proliferation blocker, terminated a majority of the proliferation in 
the spleen and anterior kidney with full termination in the blood. Due to the lack of
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proliferation, there was no ASC development or Ig secretion seen in the blood, while a 
low level was seen in the anterior kidney and spleen, suggesting the presence of ASCs in 
these tissues. This study also looked at long-term cultures and found the anterior kidney 
to contain a population of long-lived plasma cells (ASCs) up to 35 weeks after 
immunization. These cells were resistant to HU and secreted Ig without antigenic 
stimulation. The anterior kidney provides the proper environment for the storage, 
survival, and maintenance of the long-lived plasma cells, which may home back to the 
anterior kidney after their production in the peripheral lymphoid organs [8].
1.3. Transcription factors as B cell markers
Transcription factors regulate commitment to and development along the B cell 
lineage pathway and have been extensively used as B cell markers [10]. The transcription 
factors c-myc, Pax-5, RAG-1, and Xbp-1 are expressed in both mammalian and teleost 
systems. These transcription factors, along with the proliferation markers 
bromodeoxyuridine (BrdU) and PKH26 tracking dye and the Membrane IgM and 
Secreted IgM proteins, can be used as markers for the stages of B cell development, 
activation, and differentiation (Table 1, Figure 4).
Pax-5. The paired-box containing-5 (Pax-5) gene is a member of the Pax family of 
transcription factors. Members of the Pax family, including Pax-2, Pax-5, and Pax-8, 
contain a highly conserved DNA-binding paired-domain. The paired-domain is a 128 
amino acid conserved sequence found in all members of the Pax gene family. The target
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DNA binding sites (cA-regulatory elements) are recognized by the amino- and carboxy- 
terminal subdomains of the paired-domain (reviewed in [13]) [16]. The paired domain of 
Pax-5 recognizes the cA-regulatory elements in the DNA of its target genes, such as Xbp- 
1 [1, 14, 16]. Binding to the target genes allows Pax-5 to activate or inhibit expression of 
these genes.
The B cell-specific activator protein (BSAP/Pax-5) is encoded by the Pax-5 gene 
[1, 14]. Pax-5 is associated with commitment to the B cell lineage and is found 
exclusively in B cells. A study in adult mice showed that a small population of CLPs and 
pre-pro-B cells started to express Pax-5, but it is possible that these cells were on the 
verge of committing to the B cell lineage [27]. Not only is Pax-5 expression necessary for 
B cell commitment, but its continued expression is required to maintain the B cell 
identity [19, 39]. BSAP/Pax-5 is expressed from the pro-B cell stage to the mature 
B/activated B cell stages and is not expressed in plasma cells [1]. During B cell 
development, Pax-5 represses B cell lineage inappropriate genes and myeloid lineage 
genes and activates B cell specific genes [19, 63, 88]. The expression of Ig genes is 
somewhat repressed by Pax-5 [92], as is the expression of Blimp-1 and Xbp-1 [62].
19
Cs
S3
mo
*■£3
A
*-+•*
ca>flS3
&
jd
►a>
f t
33 S3a> o
U • p*<s-»
f t 68
33 sa>O i-
-=
OX) &0
o f tL.
pC ”0
H cCQ
a
#o
a>!U
Cu
*
W
&*a>-HS-
A
§
'a>
U
f t
X
bp
l
+ + + +
I
+
+ +
++
To
tal
Ig
M i
■
i i + + ++
++
Sec
 I
gM
 
HC
+L
C
i i i i l i ++
+
+
Cy
to
pl
as
m
ic 
IgM
 
HC
I l l + +
++ ++
Me
m 
Ig
M
 
HC
+L
C
I I i i + + i+ i
Me
m 
Ig
M
 
HC i i
i
+
i
+ + + + i
c-
m
yc I + + I i O- + i
RA
G1 + + + + i O- O- i
Pa
x5 + + + + + + 1+ i
Br
dU i + + i i 1 + i
Ce
ll 
Ty
pe
Pr
o-
B
Pr
e-
BI
La
rge
 p
re
-B
I
Sm
all
 p
re
-B
I
Re
sti
ng
 
M
atu
re 
B
Ac
tiv
ate
d 
B
Pl
as
m
ab
las
t
Pla
sm
a 
ce
ll
g.2 'ti 
03 c
1 |  
«§ M
|  O^  c
T3 || G " 
c d  c  -
G~ G~
.2 .2 ’-3 "c/i 
Cd C/5> 2a
& * <ui=rC o
<L>
2 0
1  * « o 'O T
CQao g<
.2 B
T3 0>
CO °
£ £  cu "4-*
i .s
G  «G(u 
O  to
a> n J-H II 
G, .
X<D (U 
.’-' 0“'5 G*
-G —,■*—» i
Td u
G °  
cd <y 
co £i-ijg.s
G C 
G  <D L- co 
<D' - J ^<L> cl o  ^
as |  g.
8  t  &'*- 2 ;=35£ <u
O d>
-G  <" , r j
co c  *
,—' cd G
« ’3 G"rt 2 <L>
^ i - 2 • 2
^ 2 + 5
-  2 S, f l  i 3 co
« C  S! 
H . 2  g.
20
Pax-5 is expressed early on in B cell development and helps to maintain B cells in 
the B cell lineage and to progress past the pro-B cell stage [64]. Pax-5 is important for the 
development of B cells, as well as the normal development of the central nervous system 
and testes in adult mice [102]. A study using Pax-5 deficient mice showed that the B cells 
were arrested at the pro-B cell stage. There were no mature B cells (membrane IgM+) 
found in the spleen, lymph nodes, or bone marrow of these mice and there were no 
plasma cells present as determined by the lack of Ig secretion [102]. Pax-5 deficient pro- 
B cells have the ability to undergo D-J recombination on the Ig heavy chain gene at levels 
comparable to wild-type mice. However, these cells show a 50-fold decrease in the V-DJ 
rearrangement on the heavy chain gene, leading to difficulties in plasma cell production 
and Ig secretion [64].
Pax-5 deficient pro-B cells have been found to lack commitment to the B cell 
lineage, but maintain their ability to proliferate [64]. In the absence of Pax-5 and the 
cytokine IL-7, pro-B cells have the potential to develop into any of the hematopoietic 
precursors [10, 58, 65]. Pax-5 deficient pro-B cells in vitro in the absence of IL-7 will 
differentiate into macrophages in the presence of the myeloid cytokine macrophage- 
colony stimulating factor (m-csf) [58]. In the absence of Pax-5 but in the presence of T 
cell growth factors, pro-B cells will differentiate into pro-T cells, both in vitro and in vivo 
[58, 78]. The reversion of pro-B cells to other hematopoietic precursors in the absence of 
Pax-5 shows the necessity of Pax-5 expression for commitment to the B cell lineage in 
early B cell progenitors.
21
The conditioned loss of Pax-5 expression in mature B cells causes them to lose 
their B cell identity through the decreased expression of IgD and other B cell specific 
genes and the loss of B cell surface proteins [39]. The re-expression of Pax-5 in the Pax- 
5-1- pro-B and mature B cells restores their B cell identity and leads to continued B cell 
development and differentiation into Ig-secreting plasma cells [65].
Pax-5 gradually decreases in mature B cells and its expression is lost upon plasma 
cell differentiation and Blimp-1 expression [10, 94]. In a study using a constructed Pax-5 
deficient DT40 chicken B cell line (membrane IgM+) an up-regulation of Blimp-1 and 
Xbp-1 expression was seen, along with an increase in IgM secretion, which are all 
characteristic changes associated with plasma cell differentiation [62]. As B cells move 
closer to plasma cell differentiation, Pax-5 levels decrease in response to rising Blimp-1 
levels. As Pax-5 expression is lost, B cells begin to express plasma cell genes and secrete 
immunoglobulin.
RAG-1. As described previously, the Recombination Activating Genes-1 and -2 (RAG-1 
and RAG-2) encode the recombinase that initiates V(D)J recombination. In mammals, 
RAG-1 and RAG-2 are present in pro- and pre-B and T cells, where they initiate 
recombination of the B cell receptor (BCR) heavy chain and light chain genes and the T 
cell receptor (TCR) genes. The RAG complex has not been detected in non-lymphoid cell 
lines or tissues [67, 87]. Studies done with RAG-/- mice show that the lymphocytes are 
blocked at the progenitor B and T cell stages (reviewed in [3]).
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RAG-1 and RAG-2 expression has been documented in zebrafish [103] and carp 
[40], where expression was seen in the anterior kidney. The location of RAG-expressing 
cells in the anterior kidney shows that there are developing B cells in this tissue, just as 
there are in the bone marrow of mammals. Zebrafish with a RAG-1 mutation showed the 
importance of V(D)J recombination and RAG expression for the progression of B cell 
development in teleosts [103].
Studies in mammals have shown that immature B cells in the bone marrow do 
indeed express low levels of RAG-1 and RAG-2 [29, 61, 106]. Low, residual levels of 
RAG-1 and RAG-2 expression are seen in immature B cells in the bone marrow, but as 
membrane IgM levels increase on these cells, RAG expression decreases [106]. A study 
done by Nagaoka, et al. [61] found that immature B cells in the bone marrow expressing 
low levels of RAG-1 and RAG-2 travel to the spleen after immunization. They suggest 
that the migration of these immature RAG-expressing B cells to the spleen after 
immunization may explain the RAG-1 and RAG-2 expression seen in peripheral 
lymphoid organs [61]. RAG-1 and RAG-2 expression was seen in B cells in the mouse 
spleen and lymph nodes after immunization [37, 69] and in mature B cells lines after 
antigenic stimulation [17, 37]. These studies suggest that immature and mature B cells 
express RAG-1 and RAG-2, but this point remains a source of debate. RAG expression 
may be seen in the immature and mature B cell stages as these cells are undergoing 
receptor editing. If the BCR on an immature B cell comes into contact and binds antigen, 
then the B cell will either undergo cell death or edit its BCR (reviewed in [34]).
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c-myc. c-myc is a protein that belongs to the myc family of basic helix-loop-helix/leucine 
zipper transcription factors. The c-myc protein must dimerize with its partner max in 
order to bind to the DNA of its target genes ([6, 73] reviewed in [52]). c-myc is known to 
be involved with cell growth, proliferation, differentiation, and/or apoptosis [24].
Expression of c-myc is seen at high levels in pro- and pre-B cells but expression 
decreases as the cells differentiate into immature, resting (IgM+) B cells [54]. Levels of 
c-myc expression increase again after antigenic stimulation as B cells are proliferating.
As B cells leave the cell cycle and differentiate into plasma cells or memory B cells, c- 
myc expression is lost [51, 54]. Studies have shown that c-myc is not only related to cell 
division, but to the cell growth that occurs before cell division [15, 31, 42]. As a cell 
prepares to divide, it increases in size and mass with an increase in protein synthesis [15]. 
c-myc may play a role in both cell growth and division, but some studies show that c-myc 
only regulates cell growth, not division [31, 42].
While its role is not completely understood, c-myc is known to be expressed at 
high levels in proliferating B cells: pro- and pre-B cells and plasmablasts. As the cells 
differentiate into immature, resting B cells or Ig secreting plasma cells, c-myc expression 
is lost [51]. The expression patterns of c-myc allow for its use as a marker to identify 
proliferating cells.
Blimp-1. B-lymphocyte induced maturation protein-1 (Blimp-1) is a transcriptional 
regulator required for plasma cell differentiation [53, 90, 91]. One of the genes that
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Blimp-1 regulates is c-myc. Blimp-1 directly represses c-myc gene expression, 
terminating proliferation and causing B cells to exit the cell cycle [55]. It is shown that 
repression of c-myc and cessation of proliferation is not enough to induce plasma cell 
differentiation. Blimp-1 must be expressed and allowed to regulate genes other than c- 
myc to allow for plasma cell differentiation [54]. Blimp-1 also binds directly to the Pax- 
5 promoter and represses Pax-5 expression. Through this action, Blimp-1 indirectly 
allows for the expression of Xbp-1 and for plasma cell differentiation to occur [53, 77, 
90].
Xbp-1. X-box binding protein-1 (Xbp-1) is a transcription factor with a basic DNA 
binding region associated with a leucine-zipper [77]. The expression of Xbp-1 is 
associated with endoplasmic reticulum (ER) stress and plasma cell differentiation. As B 
cells are preparing to differentiate into Ig-secreting plasma cells, there is remodeling of 
the secretory apparatus, including the ER. The inositol-requiring endonuclease (IRE-1) is 
activated by stress in the ER. At this point, Xbp-1 is expressed in its active form. IRE-1 
removes 26 nucleotides from the Xbp-1 mRNA, allowing for the expression of the more 
stable, active form of Xbp-1 [12].
As mentioned above, Xbp-1 is important in plasma cell differentiation and has an 
inverse relationship with Pax-5. As Pax-5 levels decrease, Xbp-1 levels increase in B 
cells [77]. Studies in Xbp-1 deficient mice showed that these mice still expressed Blimp- 
1, but Blimp-1 deficient mice did not express Xbp-1 or other plasma cell genes [90]. This 
shows that Xbp-1 is located downstream of Blimp-1 and needs Blimp-1 repression of
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Pax-5 to allow for its expression. Xbp-1 is important in promoting plasma cell 
differentiation, both through phenotypic and functional changes and through plasma cell 
gene activation. In B cells, Xbp-1 induces phenotypic changes that are characteristic of 
plasma cell differentiation. There is an increase in cell size and organelle mass, along 
with an increase in endoplasmic reticulum function and protein synthesis [91]. The 
changes occur as the B cells prepare to differentiate into plasma cells and secrete 
antibody (Ig).
Low levels of Xbp-1 expression are seen in activated B cells as Pax-5 levels 
decrease and the cells prepare for and begin to secrete low levels of immunoglobulin. 
Xbp-1 expression is at its peak in plasmablasts and plasma cells (Table 1). A study by 
Reimold et al. [77] suggests that Xbp-1 is also expressed in early B cell progenitors, the 
pre-pro-B cell, when Pax-5 levels are low. As Pax-5 levels increase, Xbp-1 expression is 
lost in the pre-B cells, where Pax-5 levels are at their highest [77]. The level of Xbp-1 
expression in early developing B cells is yet to be fully understood; however, its 
expression in later stages signifies preparation for plasma cell differentiation and 
immunoglobulin secretion.
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Figure 4. Functional interactions between B cell markers. This model is based on 
the interactions o f these markers in the mammalian system. Arrows represent 
activation and bars represent repression.
1.4. Cell proliferation markers
The use of fluorescently-labeled markers has been important in detecting cell 
proliferation, especially in lymphocytes. One of the more commonly used markers is the 
radioactive marker tritiated thymidine (3HT). This marker is incorporated into the DNA 
of replicating cells and allows for the detection of the proliferative response of an entire 
cell population to antigenic stimulation. Tritiated thymidine does not allow for the 
identification of the effects on individual cells (reviewed in [81]). This method has been
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used in both mammalian and teleost systems [8, 85], but is used less frequently now due 
to the difficulty of disposing of the radioactive waste.
Recently, two of the more commonly used proliferation markers have been the 
PKH26 tracking dye and BrdU incorporation. PKH26 tracking dye is a long-chain 
aliphatic fluorescent dye [28]. The PKH26 dye is added to cells in culture and becomes 
integrated in the lipid membrane. As the cells divide, the dye is portioned equally to each 
daughter cell, reducing the dye intensity by half with every division. When analyzed with 
flow cytometry, the cells with the highest dye intensity are the cells that are likely to 
divide and the cells with the low intensity are cells that have divided. The PKH26 
tracking dye allows for the cumulative measurement of cell proliferation in a population 
over time [2].
Bromodeoxyuridine (BrdU) is a thymidine analog that is incorporated into the 
DNA of proliferating cells [35]. BrdU provides information about the proliferating cells 
at one time point, on a single-cell level [2]. Studies with mouse and human peripheral 
blood lymphocytes (PBL) have been successful in using BrdU to look at B cell 
proliferation with flow cytometry [35, 81]. The anti-BrdU antibody or Click-iT EdU dye 
recognize and bind to the BrdU in DNA. We predicted that BrdU incorporation would 
occur at the pre-B cell and plasmablast stages when the cells were dividing (Table 1).
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1.5. Research aims, hypotheses, and significance
Based on the limited knowledge of the teleost immune system, this study was 
designed to further explore B cell development, activation, and differentiation in the 
rainbow trout (Oncorhynchus mykiss). The focus of this thesis research was to further 
characterize the B cells populations in the immune tissues of the rainbow trout and 
determine a B cell profile for each tissue.
The hypotheses for this study are represented in the model seen in Figure 4 [108]. 
This model shows the proposed movement of B cells throughout the kidney, spleen, and 
blood of the rainbow trout. B cell development and maturation is illustrated as occurring 
in the anterior kidney. The mature, resting B cells of the anterior kidney then move to the 
posterior region of the kidney or travel via the blood to the spleen. In these peripheral 
lymphoid organs, the resting B cells encounter antigen and become activated, proliferate, 
and differentiate into plasma cells. The plasma cells may remain in the periphery or they 
may home back to the anterior kidney for storage as long-lived plasma cells.
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Figure 5. B cell development, activation, and differentiation in the trout immune system. This Figure 
shows a model for B cell development, activation, and differentiation in the different lymphoid organs of 
the trout, as proposed by the Zwollo lab [108].
1.5.1. Aim 1: To identify a marker for proliferating trout B cells using flow 
cytometry.
Very few studies have been conducted on B cell proliferation in the rainbow trout.
n . . .Previous studies used HT to look at cell proliferation in the anterior kidney, spleen, and 
blood of the trout with success [8, 108]. However, this approach does not allow for the 
concomitant identification of the proliferating cells as B cells. Therefore, we wished to 
identify proliferation markers for flow cytometry that would allow for the use of multiple 
markers per cell and enabling the identification of proliferating B cells. Three different 
proliferation markers, BrdU, c-myc, and PKH26 tracking dye, were tested.
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1.5.2. Aim 2: To determine the B cell profiles of freshly isolated trout immune cells 
from the anterior and posterior kidney, spleen, and blood using two-color flow 
cytometry.
This study aimed to identify the types of B cell populations present in freshly 
isolated immune tissues of the rainbow trout. Two-color flow cytometry using 
combinations of the fluorescent markers BrdU, Pax-5, RAG-1, Membrane IgM, Secreted 
IgM, Total IgM, and Xbp-1 was used to analyze the B cell populations within the trout 
spleen, blood, and anterior and posterior kidney.
Since the teleost anterior kidney is functionally homologous to the mammalian 
bone marrow, we predicted that we would see B cell development occurring in the 
anterior kidney of the trout. We hypothesized that in the absence of immunization, the 
anterior kidney contains a diverse population of immune cells, including populations of 
developing B cells with the phenotype: BrdU+ or -/Pax-5+/RAG-l+ or -/Membrane 
IgM-/Secreted IgM-/Total IgM-/Xbp-l+, as well as a small population of ASCs.
There is little known about the B cell profile of the posterior kidney and it may 
contain a mixture of B cells at various stages of activation. We hypothesized that, prior to 
LPS-activation, the majority of the lymphocytes in the posterior kidney are either resting, 
mature B cells, activated B cells, or ASCs.
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As secondary immune organs, we hypothesized that the majority of lymphocytes 
in the spleen and blood prior to LPS-activation are resting, mature B cells with the 
phenotype: BrdU-/Pax-5+/Membrane IgM+/RAG-l-/Secreted IgM-/Total IgM+/Xbp- 
1+.
1.5.3. Aim 3: To determine the B cell profiles of LPS-activated trout immune cells 
from the anterior and posterior kidney, spleen, and blood using two-color flow 
cytometry.
In order to identify the changes seen in the B cell populations in the immune 
tissues of the rainbow trout after antigenic stimulation, immune cells from the trout 
anterior and posterior kidney, spleen, and blood were LPS-activated and cultured ex vivo. 
Two-color flow cytometry using combinations of the markers BrdU, Pax-5, RAG-1, 
Membrane IgM, Secreted IgM, Total IgM, and Xbp-1 was used to analyze the B cell 
populations in the trout immune tissues after LPS-activation.
Developing B cells are insensitive to LPS, therefore we hypothesized that after 
stimulation with LPS we would continue to see a large population of developing B cells 
in the anterior kidney with the phenotype: BrdU+/Pax-5+/RAG-l+/Membrane 
IgM-/Secreted IgM-/Total IgM-/Xbp-l+. As a storage site for ASCs both before and 
after LPS-activation, we hypothesized that we would see IgM secreting, high Xbp-1 
expressing cells in addition to the developing B cells in the anterior kidney.
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After LPS-activation, we hypothesized that the population of resting B cells in the 
spleen, blood, and posterior kidney would decrease in frequency and in turn, the 
frequency of the activated B cell, plasmablast, and plasma cell populations in these 
tissues would increase.
To monitor B cell activation, supernatants from LPS-activated trout anterior and 
posterior kidney, spleen, and blood B cells were analyzed for total IgM levels using 
ELISAs. We hypothesized that we would see higher IgM production in the anterior 
kidney, posterior kidney, and spleen. IgM secretion has been documented in the spleen 
and anterior kidney [8] and as a secondary immune organ, we expected the posterior to 
secrete IgM as well. We expected to see lower levels of IgM secretion in the blood as this 
tissue produces low numbers of plasma cells.
1.5.4. Significance
The results from this study have the potential to provide new understanding of the 
development, maintenance, and functions of the immune system of rainbow trout and 
other teleosts. The patterns of B cell populations within each trout immune tissue would 
allow for the development of a “B cell profile” for each immune site. This could then be 
applied to disease studies, or to other teleosts systems, such as the salmon or carp.
Using various combinations of B cell markers, two-color flow cytometry can 
provide information on the B cell populations present within the spleen, blood, and
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kidney of the trout. With this method we can identify which B cell populations are 
present in the immune tissues before and after activation/antigenic stimulation. By 
comparing the staining patterns of the markers before and after activation/antigenic 
stimulation, we can begin to characterize B cell responses to pathogens.
Many teleosts, including salmon (Salmo salar) and rainbow trout (Oncorhynchus 
mykiss), are commercially grown as aquaculture species. Fish grown in this environment 
are susceptible to various diseases, especially at the juvenile stage. As the aquaculture 
industry continues to grow, the need to maintain fish health is important. Understanding 
the teleost immune system will allow for the development of vaccines to protect the fish, 
without having to treat them with antibiotics or drugs.
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CHAPTER II
Methods
2.1. MPC11 cell line
The murine plasmacytoma line MPC11 was purchased through the American 
Type Culture Collection (ATCC) and grown according to ATCC guidelines. The cells 
were maintained at a concentration of 1-5x105 cells/ml in Mouse Complete Medium 
(MCM) consisting of RPMI 1640 medium supplemented with 10% fetal bovine serum 
(FBS; Bio Whitaker, Inc.), 2 mM glutamine, 50 units/ml penicillin, 50 pg/ml 
streptomycin, and 50 pM beta-mercaptoethanol.
2.2. Mouse tissue collection
Three-month old male Y0 84b mice were a gift from Dr. Eric Bradley. Mice were 
euthanized through asphyxiation with CO2 , followed by cervical dislocation, in 
accordance with IACUC protocol. The spleen was removed and placed into a Petri dish 
(Falcon, BD Biosciences) filled with 2 ml HBSS (137 mM NaCl, 5.6 mM D-glucose, 5 
mM KC1, 8.1 mM Na2 HPC>4 « 2H20 , and 20 mM Hepes at pH 7.05). The tissue was 
repeatedly aspirated using a 10 ml syringe and forced through a 40 nm nylon cell strainer 
(Falcon, BD Biosciences) to create a single-cell suspension. The cells were centrifuged 
for 10 min at 1300 rpm at 4°C. The supernatant was removed and the pellet was 
resuspended in 10 ml HBSS. The cells were centrifuged for 5 min at 1000 rpm at 4°C.
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This procedure was repeated two times. The supernatant was removed and the pellet was 
resuspended in 5 ml MCM at a concentration of 106 cells/ml.
2.3. Rainbow trout and facilities
Out-bred rainbow trout (200-500 grams) were purchased from Casta Line Trout 
Farms (Goshen, VA). Fish were maintained in a 100-gallon tank with a re-circulating 
system employing biologically-filtered well water. Fresh water exchange was 
approximately 10% per day. Water temperature was maintained at 12°C. Fish were fed 
dry, floating pellets (Aqua Max Grower 600, Purina) once a day.
2.4. Trout tissue collection
Trout were anesthetized with ethyl-3-Aminobenzoate methanesulfate salt (Sigma) 
in accordance with our IACUC protocol. Blood (2-5 ml) was drawn from the caudal vein 
and placed into heparinized tubes. The spleen, anterior kidney and posterior kidney were 
collected and placed into Petri dishes filled with 2 ml HBSS. The tissue was repeatedly 
aspirated using a 10 ml syringe and then forced through a 40 nm nylon cell strainer 
(Falcon, BD Biosciences) to create a cell suspension for each tissue. The cells were 
centrifuged for 10 min at 1300 rpm at 4°C and the supernatant was removed. The cells 
were resuspended in 10 ml HBSS and centrifuged for 10 min at 1300 rpm at 4°C. The 
supernatant was removed and the pellet was resuspended in 10 ml HBSS. In a separate 50 
ml Falcon tube, 10 ml of Histopaque (1077, Sigma Aldrich) was added. The cell
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suspension was layered onto the Histopaque and the cells were centrifuged for 30-45 min 
at 2100 rpm at 4°C. The supernatant, including the cell layer, was removed and 
transferred to a new 50 ml Falcon tube. The volume was increased to 45 ml with HBSS 
and the cells were centrifuged for 10 min at 1300 rpm at 4°C. The supernatant was 
removed and the cells were resuspended in 10 ml HBSS. Cells were centrifuged for 10 
min at 1300 rpm at 4°C and the supernatant was removed. The pellet was resuspended in 
5 ml trout complete medium (TCM). The cells were counted using a hemacytometer 
(Fisher Scientific) and cell concentrations were determined for each tissue.
2.5. LPS activation
Fresh trout cells: Cells were resuspended in trout complete medium (TCM) consisting of 
RPMI 1640 with 10 mM L-glutamine, 10% fetal calf serum (FCS), 50 g/ml gentamicin, 
50 M 2-ME, and the nucleosides adenosine, uracil, cytosine, and guanosine (10 g/ml;
n
Sigma-Aldrich) at a concentration of 10 cells per 1 ml of medium. The B cell mitogen 
lipopolysaccharide (LPS, 055:B5 from E. coli, Sigma) was added to the cells at 100 
pg/ml to activate the B-lymphocytes. The cell suspension was transferred to a 24-well 
culture plate (Coming, BD Biosciences) at 2xl07 cells (2 ml) per well. The cells were 
grown at 18°C in the presence of blood gas (10% CO2 , 10% O2 , 80% N2 ). Anterior 
kidney cells were collected everyday for 7 days and posterior kidney cells were collected 
everyday for 5 days. Spleen and blood cells were collected every other day over a 10-day 
period. Cells were fed every other day with one-tenth of the culture volume of a 1 Ox 
tissue culture cocktail containing 500 pg/m gentamycin, lOx essential amino acids (aas),
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lOx non-essential aas, 70 mM L-glutamine, 70 mg/ml dextrose, lOx nucleosides, and 
33% FBS.
Fresh mouse spleen cells: Cells were resuspended in MCM at a concentration of 107 
cells/ml. The B cell mitogen LPS was added to the cells at 20 pg/ml to activate the mouse 
B-lymphocytes. The cell suspension was transferred to a 24-well culture plate (Coming, 
BD Biosciences) at 107 cells/ml and 1ml per well. The mouse spleen cells were grown at 
37°C in a CO2 incubator (5.0% CO2 ) and were collected every 24 hr over a 4-day period. 
Cells were fed every other day with MCM at one-fifth of the culture volume.
2.6. BrdU incorporation
Bromodeoxyuridine (BrdU kit, Invitrogen) was added to cells in culture at a final 
concentration of 3pg/ml. Trout cells were incubated with BrdU in culture for 18 hr, 
mouse spleen cells were incubated for 3 hr, and MPC11 cells were incubated for 16 hr 
before they were collected and fixed (see section 2.9).
2.7. PKH26 tracking dye
Cells were collected in 15ml Falcon tubes to be stained with PKH26 tracking dye 
(Red Fluorescent Cell Linker Mini Kit, Sigma). The cells were centrifuged for 5 min at 
15000 rpm at 25°C and the supernatant was removed. The pellet was resuspended in 1ml 
trout medium without serum for trout cells and mouse medium without semm for mouse
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spleen and MPC11 cells. The cells were centrifuged as above. The cell pellet was 
resuspended in 1 ml Diluent C (Red Fluorescent Cell Linker Mini Kit, Sigma). 
Immediately prior to staining, a 4 pM PKH26 dye reagent was prepared by diluting 4 pi 
of 1 mM PKH26 dye in 1ml of Diluent C. The cells were rapidly added to the 1 ml of 
staining solution and resuspended. The cells were incubated with the dye for 3 min at 
25 °C with periodic inversion of the tube. After the 3 min incubation, 2 ml PBS 
containing 1% Bovine Serum Albumin (BSA) was added to the cells and they were 
incubated for 1 min at 25°C. The cells were then diluted with 4 ml TCM for trout cells or 
MCM for mouse spleen and MPC11 cells and were centrifuged for 10 min at 1500 rpm at 
25°C. The supernatant was removed and the cells were resuspended in 1 ml TCM for 
trout cells or complete MCM for mouse spleen and MPC11 cells and then were 
transferred to a new tube for washing. The 1 ml of cell suspension was resuspended in 9 
ml TCM for trout cells or 9 ml MCM for mouse spleen or MPC11 cells. The cells were 
centrifuged for 5 min at 1500 rpm at 25°C and the supernatant was removed. This was 
repeated for a total of three washes. After the third wash, all of the supernatant was 
removed and the cells were resuspended in 2 ml TCM for trout cells or MCM for mouse 
spleen and MPC11 cells. The cells were grown in culture for 24 hr and collected at 24- 
hour intervals for a total of 96 hr or 4 days. For starvation experiments, the cells were not 
fed during this time in culture.
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2.8. Staining fresh trout cells with anti-IgM antibody
Fresh trout cells were counted and half of the cells were taken to be “pre-stained” 
with a monoclonal mouse anti-trout total IgM antibody (Warrs 1-14 [20]). The cells were 
centrifuged for 5 min at 1000 rpm at 4°C. The supernatant (containing secreted Ig) was 
saved and stored at -20°C for use in enzyme-linked immunosorbant assays (ELISA). The 
pellet was resuspended in 10 ml Staining Buffer (PBS+ 2% FBS+ 1 mM EDTA) and 
centrifuged for 5 min at 1000 rpm at 4°C. The supernatant was removed and the pellet 
resuspended in 1.5 ml staining buffer. The mouse anti-trout total IgM 555 antibody 
(Warrs 1-14) was added to the cells at 1 pg/1.5ml. The cells were incubated for 35 min at 
4°C on a rotating platform, protected from light. After the incubation, the cells were 
centrifuged for 5 min at 1000 rpm at 4°C and the supernatant was removed. The pellet 
was resuspended in 1 ml staining buffer and spun for 5 min at 1000 rpm at 4°C. This was 
repeated for a total of 2 washes. The cells were then fixed and permeabilized (see section 
2.9).
2.9. Cell fixation and permeabilization
Cells were centrifuged for 5 min at 1000 rpm at 4°C. The supernatant (containing 
secreted Ig) was saved and stored at -20°C for use in ELISA assays. The pellet was 
resuspended in 1 ml PBS (1.9 mM NaH2P 0 4»H20 , 8.1 mM Na2HP04* 7H20 , 137 mM 
NaCl, and 2.6 mM KC1, pH 7.4) containing 0.02% NaN2 and cells were centrifuged for 5 
min at 1000 rpm at 4°C. The supernatant was removed and the pellet resuspended in 1ml
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1% Paraformaldehyde (16% PF solution, E-M grade; Electron Microscopy Sciences) in 
PBS and incubated on ice for 15 min. Next the cells were centrifuged for 5 min at 1000 
rpm at 4°C. The supernatant was removed and the pellet resuspended in 1 ml PBS 
containing 0.02% NaN3 . The cells were centrifuged for 5 min at 1000 rpm at 4°C and the 
supernatant removed. The cell pellet was vortexed until the cells were in suspension and 
1 ml of 80% ice-cold methanol was added drop-wise to the cells while vortexing. The 
cells were stored at
-20°C for a minimum of 16 hr and remained stable at -20°C for up to 6 weeks.
2.10. One- and two-color flow cytometry
Immediately before use, fixed and 80% methanol-permeabilized cells were 
removed from -20°C storage and 1 ml ice-cold PBS + 0.02% NaN3 was added to the 1 ml 
of 80% cell suspension. The cells were centrifuged for 5 min at 1500 rpm at 4°C and the 
supernatant was removed. Cells were re-fixed as described but for 10 min instead of 15 
min. Next, the cells were resuspended in 1ml permeabilizing solution (BD perm wash, 
BD-Biosciences) containing 2% FBS and counted. A concentration of (0.5-1 xlO6 cells x 
# of samples) was used. Cells were centrifuged for 5 min at 1500 rpm at 4°C. The 
supernatant was removed and the cells were resuspended in perm wash+ 5% FBS in a 
volume of (# of samples + 1) x 45 pi. The cells were incubated for 15 minutes on a 
nutator at 4°C. Fluorescent antibodies were diluted to lOx stock solutions at a 
concentration of 0.15 pg/ml in perm wash+ 5% FBS. From each freshly diluted antibody 
solution 5 pi was added to the 45 pi cell sample and gently resuspended. The cells were
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incubated with the fluorescent antibodies for 90 min at 4°C on a rotating platform, 
protected from light. After the 90 min incubation, 1 ml perm wash+ 2% FBS was added 
to each sample. The cells were incubated for 10 min at 4°C on the nutator, protected from 
light. After the 10-min incubation, the cells were centrifuged for 3 min at 2000 rpm at 
4°C and the supernatant was removed. This wash and 10 min incubation was repeated 
once more. The pellet was resuspended in 200 pi perm wash+ 2% FBS and the cell 
suspension was transferred to a 96 well round-bottom plate (Fisher). The samples were 
immediately analyzed by flow cytometry (BD FACSArray, BD-Biosciences). For each 
sample, 50,000 cells were acquired. From this mixture of cells, a gate was placed around 
the lymphoid population to exclude red blood cells and debris from analysis.
Flow data were analyzed using the WinMDI software, version 2.8.
2.11. Click-iT EdU flow cytometry
Mouse or trout cells were fixed as described above, and incubated in the presence 
of fluorescent antibodies as before. After the 90 min incubation in the presence of 
fluorescent antibodies, 1ml perm wash+ 2% FBS was added to each sample and the cells 
were resuspended. The cells were centrifuged for 3 min at 2000 rpm at 4°C and the 
supernatant was removed. While the cells were spinning, the Click-iT EdU reaction 
buffer additive and Click-iT EdU reaction cocktail (Invitrogen) were prepared as follows: 
First, the lx Click-iT EdU buffer additive was prepared by diluting the lOx solution 1:10 
in deionized water. Second, the fluorescent dye azide was diluted 1:8 in perm wash+ 5% 
FBS. Finally, the Click-iT EdU Reaction Cocktail (438 pi reaction buffer, 10 pi CuSC>4 ,
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2.5 (4,1 Alexa 647 fluorescent dye azide, 50 pi Click-iT reaction buffer additive) was 
prepared for each sample. After the spin, each cell pellet was resuspended in 500 pi of 
the Click-iT Reaction Cocktail and the cells were incubated for 30 min at 25°C (room 
temperature), protected from light. After the 30-min incubation, the cells were washed 
twice as above. The pellet was resuspended in 200 pi perm wash+ 2% FBS and the cell 
suspension was transferred to a 96 well round-bottom plate (Fisher). The samples were 
immediately analyzed by flow cytometry (BD FACSArray, BD-Biosciences), as 
described previously (see section 2.10).
2.12. BrdU one-color flow cytometry
Immediately before use, MPC11 cells were removed from -20°C storage and 
resuspended in 500 pi ice-cold PBS with 0.02% NaN3 . Cells were centrifuged for 2 min 
at 3000 rpm at 4°C. The supernatant was removed and the pellet was resuspended in 1 ml 
permeabilizing solution (BD perm wash, BD-Biosciences) and counted. A concentration 
of (106 cells x # of samples) was used. The cells were centrifuged as before and the 
supernatant was removed. The pellet was resuspended in 100 pi BD Cytoperm Plus 
Buffer (BrdU kit, BD Biosciences) and incubated on ice for 10 min. The cells were 
centrifuged as before. The pellet was resuspended in 1 ml permeabilizing solution and 
centrifuged as before. The cells were resuspended in 100 pi BD Cytofix/Cytoperm Buffer 
(BrdU kit, BD Biocsciences) and incubated on ice for 5 min. The cells were centrifuged 
as before. The pellet was resuspended in 1 ml permeabilizing solution and centrifuged as 
before. The DNase solution was prepared by diluting the DNase (BrdU kit, BD
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Biosciences) 1:3 in PBS. The pellet was resuspended in 100 pi ice-cold DNase solution 
and incubated for 1 hr at 37°C. The cells were centrifuged as before and resuspended in 1 
ml permeabilizing solution. The cells were centrifuged as before. This process was 
repeated for a total of two washes. The supernatant was removed and the cells were 
resuspended in perm wash+ 5% FBS in a volume of (# of samples + 1) x 45 pi. The cells 
were incubated for 15 min on a rotating platform at 4°C. Fluorescent antibodies were 
diluted to lOx stock solutions at a concentration of 0.15 mg/ml in perm wash+ 5% FBS. 
From each freshly diluted antibody solution 5 pi was added to each sample and gently 
resuspended. The cells were incubated with the fluorescent antibodies for 20 min at room 
temperature on the nutator, protected from light. After the 20-min incubation, 1ml 
permeabilizing solution was added to each sample and the cells were resuspended. The 
cells were centrifuged as before and this wash was repeated twice. The supernatant was 
removed and the pellet was resuspended in 200 pi staining buffer (PBS containing 3% 
FBS and 0.09% NaNs). The cell suspension was transferred to a 96-well round bottom 
plate (Fisher) and the samples were immediately analyzed by flow cytometry (BD 
FACSArray, BD-Biosciences), as previously described (see section 2.10).
2.13. Antibodies
The c-myc, Pax-5, RAG-1, Secreted IgM, Total IgM (Warrs), and Xbp-1 
antibodies (Table 2) were conjugated to Alexa 555 or Alexa 647 using protein-labeling 
kits (Molecular Probes, Invitrogen). Antibodies were labeled according to manufacturers 
instructions. Frozen aliquots were stored at -80°C.
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Fluorescent Markers Used With Flow Cytometry
Source Name Target Peptide Type of Antibody
Purchased
(Invitrogen)
Click-iT EdU BrdU N/A*
Purchased
(Invitrogen)
BrdU BrdU mouse monoclonal 
IgG
Purchased 
(Santa Cruz 
Biotechnology 
Inc.)
c-myc
(N-262)
c-myc 
aa 1-262
rabbit anti-human 
polyclonal IgG
In-house
[110]
Pax-5 (ED-1) Trout BSAP/Pax-5 
148aa of paired domain
polyclonal anti­
paired domain IgG 
(ED-1)
Purchased 
(Santa Cruz 
Biotechnology 
Inc.)
RAG-1
(FI-300)
RAG-1 
aa 744-1043
rabbit anti-human 
polyclonal IgG
In-house
(Gen-script)
[109]
Secreted IgM Trout Secreted IgM 
WLVDDEPVERTSSS
polyclonal rabbit- 
antiserum Secreted 
IgG
Gift from Dr. 
Steve Kaattari 
[20]
Warrs (1-14) Trout Membrane and 
Secreted IgM
mouse anti-trout 
Ig HC monoclonal 
IgG
In-house
(Gen-script)
t-Xbp-1 Trout Xbp-1 
SGYERSPSPFSDMSS 
PLCSEGSWDDVFANEL
rabbit anti-trout 
IgG
Table 2. Fluorescent antibodies used in thesis work. Table 2 presents the antibodies used, their source, full 
name, target peptide, and type o f antibody. *Click-iT EdU is not an antibody. This is a chemical reaction 
resulting in the binding o f the Click-iT dye azide to the BrdU in the DNA.
2.14. ELISA
A 96 well microtiter plate (Falcon, BD Biosciences) was coated with 50pi 
(2pg/ml) of the monoclonal mouse anti-trout total IgM antibody (Warrs 1-14 [20]). The 
Warrs antibody was diluted at 1:500 in PBS containing 0.05% NaN3 . The plates were 
incubated with the primary antibody at 4°C overnight.
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Next, the plate was washed with TBST Buffer (10 mM Tris-Cl, pH 8.0, 150 mM 
NaCl, 0.05% Tween 20). This was repeated for a total of three washes.
300 pi of Blocking Buffer was added to each well and the plate was incubated for 1 hr at 
room temperature while gently shaking. After the incubation, the plate was washed three 
times with TBST Buffer. Trout supernatants were diluted 1:4 in PBS with 0.05% NaN3 . 
Fifty microliters of the sample was added to each well. Each sample was performed in 
triplicate. As a negative control TCM was diluted 1:4 in PBS with 0.05% NaN3 . As a 
positive control, trout serum was used either undiluted or at a dilution of 1:10 or 1:100 in 
PBS with 0.05% NaN3 , and 50 pi was added to the wells. The plate was incubated for 1 
hr at room temperature while gently shaking. After the incubation, the plate was washed 
three times with TBST Buffer as before. The secondary antibody, mouse-anti-trout IgM 
(Warrs 1-14) with a biotin label, was diluted at 1 pg/ml in Blocking Buffer and 50 pi was 
added to each well. The plate was incubated for 1 hr at room temperature while gently 
shaking. After the incubation, the plate was washed three times as before. A streptavidin- 
HRPO solution was prepared by diluting the streptavidin-HRPO (1 mg/ml) in Blocking 
Buffer and 50 pi was added to each well. The plate was incubated for 1 hr at 25°C while 
gently shaking. After the incubation, the plate was washed 5 times with TBST as before. 
The ABTS developer [8.4 ml Citrate Buffer, 100 pi 10% ABTS (2-2’Azino-bis(3- 
ethylbenzothiazoline-6-sulfonic acid) diammonium salt~98%; Sigma), 5 pi 30% H2 O2 
(Sigma-Aldrich)] was prepared and 50 pi was immediately added to each well. Plate was 
read by a microplate reader (Model 550, BioRad) with a filter at a wavelength of 405nm 
after 5 and 10 min. ELISA data analyzed using Microsoft Excel.
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CHAPTER III
Results
3.1. Analysis of cell proliferation using one-color flow cytometry
The ultimate goal of this proliferation study was to find a marker to identify 
proliferating B cells in the rainbow trout and use this marker for further studies of this 
organism. This study aimed to test three separate markers for detecting cell proliferation: 
BrdU incorporation, c-myc, and PKH26 tracking dye. Each marker was analyzed with 
one-color flow cytometry for cell proliferation. Before the frequencies of the stained cell 
populations were determined, dot plots were made and the lymphocyte population gated. 
The forward-scatter (FSC) and side-scatter (SSC) properties of the cells are used to 
determine the location of the lymphocyte population from the total tissue cell mixture. 
FSC provides information about the size of the cell and the SSC provides information 
about the internal complexity of the cells. For this study, the proliferation markers were 
analyzed against cell size (FSC) and shown as contour plots.
Contour plots display the density of the cell population. In contour plots, the 
individual events of a dot plot are replaced by contour lines and resemble a topographic 
map. As the contours become more compact, the higher the density of cells at that point, 
expressing that intensity of the marker. Contour lines are shown as log algorithms with 
intervals of 50% [93].
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We hypothesized that we would see varying populations of proliferating cells in 
each of our systems using the three different proliferation markers with one-color flow 
cytometry. No B cell specific markers were used in conjunction with the proliferation 
markers and we therefore were unable to distinguish proliferating B cells from 
proliferating T or other non-B cells in this experiment.
The timing of proliferation and location of proliferating B cells in trout immune 
tissues are poorly understood, hence, the initial goal of this thesis work was to find usable 
proliferation markers for the trout immune system. In mammals, B cell proliferation 
occurs at two time points during the life of a B cell: during B cell development in pro- 
and pre-B cells and again as plasmablasts. The three proliferation markers were tested in 
three different systems: the MPC11 plasmacytoma line, mouse spleen cells, and trout 
anterior kidney and spleen cells. Mouse spleen cells and trout anterior kidney and spleen 
cells were placed in culture and activated with the B cell mitogen Lipopolysaccharide 
(LPS) to activate the B cells and induce proliferation.
3.1.1. Cells used in the study
MPC11 cell line. The well-defined murine plasmacytoma cell line MPC11 is known to 
incessantly divide every 16-20 hours, making it an ideal model for testing proliferation 
markers. This cell line does not require activation with LPS for proliferation to occur and 
any proliferation we detected with the proliferation markers was B cell proliferation.
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BrdU incorporation and PKH26 tracking were tested in this system for detection of B cell 
proliferation.
Mouse spleen cells. The mouse is a well-accepted and well-defined model organism for 
immunology studies. Previous work (See Chapter I) has shown that populations of 
proliferating B cells are present in the mouse spleen after stimulation, thus making the 
mouse a model system for use in this study. The proliferation markers BrdU and c-myc 
were tested in this model. Detection of proliferation with these markers in the mouse was 
used to show that we could use these methods to detect proliferation in the trout.
Trout anterior kidney cells. The anterior kidney of the rainbow trout is hypothesized to 
contain a large population of developing B and T cells, including proliferating pre-B and 
T cells. There may also be a smaller population of plasmablasts in this tissue. To identify 
the populations of proliferating cells in the anterior kidney, the cells were analyzed with 
one-color flow cytometry using the proliferation markers BrdU, c-myc, and PKH26 
tracking dye.
Trout spleen cells. The trout spleen is hypothesized to be a site of antigen encounter and 
activation for B cells. We would expect to see a population of proliferating plasmablasts 
in this tissue. The samples in this study were a mixture of immune cells and may contain 
proliferating T cells as well as B cells. Trout spleen cells were analyzed with one-color 
flow cytometry using BrdU incorporation, c-myc, and PKH26 tracking dye as markers 
for cell proliferation.
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3.1.2. Analysis of proliferation markers using one-color flow cytometry
BrdU incorporation. Bromodeoxyuridine (BrdU) is a thymidine analog that is 
incorporated into newly synthesized DNA of proliferating cells. In one method of 
detection, an anti-BrdU antibody binds to the BrdU in the DNA, identifying the 
proliferating B and T cells. A newer method, used here in the mouse and trout cells, is the 
Click-iT EdU method. This method uses a chemical reaction to bind a fluorescent dye 
azide to the BrdU in the DNA. The MPC11 cells, mouse spleen cells, and trout anterior 
kidney and spleen cells were incubated with BrdU in culture before collection. The cells 
were then fixed and permeabilized. MPC11 cells were stained with the fluorescent anti- 
BrdU antibody while the mouse and trout cells were incubated with the Click-iT dye 
reagent. All cells were analyzed by one-color flow cytometry for the proliferating cells.
Figure 6 depicts the contour plots of the MPC11 cells with BrdU incorporation 
and FSC (cell size) as the parameters. The cells were grown in culture for four days with 
BrdU added at the last 16 hours of incubation. Once a day, 106 cells were collected, fixed, 
and permeabilized. There is a population of cells with high proliferation occurring on 
Days 0 and 3 and a population of cells with low proliferation on Days 2 and 4. The lower 
proliferation on Days 2 and 4 may be due to the cells being fed on Day 2 and Day 4 in 
culture, as fresh nutrients are likely to boost proliferation in cells.
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Using normal mouse splenic B cells after LPS induction, a population of 
proliferating cells was observed on each of the five days measured (Day 0-4). As shown 
in the contour plots in Figure 7A, the proliferating cells are relatively large cells (high 
FSC), supporting the assumption that they most likely represent plasmablasts or 
proliferating T cells. This population increased over the 4-day culture period, with 15.8% 
of cells proliferating on Day 4, as seen in the graph depicted in Figure 7B.
Using trout splenic cells, we saw a population of proliferating cells present on 
Days 1-7 after LPS activation (Fig. 8). The proliferating cells are largest on Day 1 and 
show high BrdU incorporation. The cells then decrease in size and show a range of BrdU 
incorporation, from intermediate to high. By Day 6, the cells have increased in size again 
and still show a range of BrdU incorporation. These cells are most likely plasmablasts or 
proliferating T cells.
In summary, in each of the three systems tested here (MPC11 cells, mouse spleen 
cells, and trout spleen cells) we detected dividing cell populations using the BrdU 
proliferation marker.
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Figure 6. BrdU incorporation in MPC11 cells. One-color flow cytometry showing BrdU 
incorporation and cell size (FSC) on fixed and permeabilized M PC11 cells over a 4-day LPS- 
activation period, Days 0-4 (D0-D4). Cell populations on the right side o f each graph represent 
BrdU+ proliferating cells. Numbers indicate percent cells in each region.
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Mouse Spleen
A. BrdU vs. FSC
Day 0-4
90.4 9.698.4
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Figure 7. BrdU incorporation in mouse spleen cells. Analysis o f BrdU incorporation in 
fixed and permeabilized mouse spleen cells over a 4-day LPS-activation period. A. Contour 
plots o f one-color flow cytometry looking at BrdU incorporation and cell size (FSC). Cells on 
the right side o f the line represent BrdU+ proliferating cells. B. Line graph o f the proliferating 
(BrdU+) cell population. One representative experiment seen here.
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Spleen
BrdU vs. FSC
Day 1-7
BrdU
Figure 8. BrdU incorporation in trout spleen cells. One-color flow cytometry looking at BrdU 
incorporation and cell size (FSC) on fixed and permeabilized trout spleen cells over a 7-day LPS- 
activation period. Proliferating cells are seen on the right side o f each graph. Numbers represent 
percent cells in each region. One representative experiment. C - Control, D= Day.
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c-myc. As discussed in the introduction, the protein c-myc is expressed during cell 
proliferation, and should therefore provide a good proliferation marker for our studies. 
Mouse spleen cells and trout anterior kidney and spleen cells were stained with the 
fluorescent anti-c-myc antibody and analyzed for proliferation by one-color flow 
cytometry. Proliferation was detected in both tissues with this marker, but no B cell- 
specific markers were used and we were unable to identity proliferating B from 
proliferating T cells.
When looking at c-myc expression in mouse spleen cells, we did not see any 
change in the population during the activation period. At all time points during the 
culture period, we saw two distinct populations: one with intermediate FSC and one with 
high FSC (Figure 9). We did not see a change in c-myc intensity in the population over 
the 4-day LPS-activation period as compared to Day 0.
Similar results to those of the mouse spleen were seen when looking at c-myc 
expression in the anterior kidney. In Figure 10 we see a population of cells with low FSC 
and a population of cells with intermediate FSC. Only very low c-myc expression was 
detected in these cells over the 6-day LPS-activation period.
The relationship between c-myc staining intensity and cell size (FSC) in trout 
spleen cells is examined in Figure 11. As was seen in the mouse spleen and trout anterior 
kidney, we saw in the trout spleen two distinct cell populations of different sizes, one 
with low/intermediate FSC and one with high FSC. On Day 0 there is a population of
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larger cells that show a slightly higher staining intensity for c-myc. This population is 
most likely plasmablasts or proliferating T cells. The c-myc intensity in this population 
showed no significant change by Day 7 after LPS-activation.
We did not see c-myc expression in the mouse spleen or trout anterior kidney 
cells before or after LPS-activation (Figures 9-11). However, a population of cells 
showing a slightly higher c-myc staining intensity was seen in the trout spleen cells on 
Day 0 before LPS-activation. These cells have a high FSC and may represent 
plasmablasts or proliferating T cells. There was no c-myc expression detected on Day 7 
in the trout spleen cells, so we did not see any c-myc expression in either the mouse or 
the trout after LPS-activation.
56
Mouse Spleen
c-myc vs. FSC
Day 0-4
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Figure 9. c-myc expression in mouse spleen cells. One-color flow cytometry using c-myc and cell 
size (FSC) on fixed and permeabilized mouse spleen cells over a 4-day LPS-activation period. One 
representative experiment shown here.
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Anterior Kidney
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Figure 10. c-myc expression in trout anterior kidney cells. One-color flow cytom etry 
looking a t c-myc and  cell size (FSC) on fixed and perm eabilized tro u t an te rio r kidney cells over 
a 5-day LPS-activation period. One represen ta tive  experim ent show n here. C= Control, D= Day.
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Trout Spleen
c-myc vs. FSC
Day 0 and Day 7
DO
D7
c-myc
Figure 11. c-myc expression in trout spleen cells. One-color flow cytom etry 
looking a t c-myc and cell size (FSC) on freshly isolated (DO) and LPS-activated (D7) 
fixed and perm eabilized tro u t spleen cells. One represen ta tive  experim ent show n 
here.
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PKH26 tracking dye. PKH26 tracking dye is a method for tracking cell proliferation 
through dye intensity in a cell population. The dye penetrates and attaches to lipids in the 
cell membrane. As the cells divide, the amount of dye per cell decreases. MPC11 and 
trout anterior kidney and spleen cells were stained with the PKH26 dye and placed in 
culture. The cells were collected every 24 hours and analyzed by one-color flow 
cytometry for cell proliferation. The earliest cells (Day 0 or Day 1, depending on 
experiment) are expected to contain the most dye and have the highest intensity for 
PKH26 since they have not yet divided. As the cells proliferate, the amount of dye in 
each cell and the intensity of PKH26 will decrease. The proliferating cells seen in each 
tissue may be either B or T cells, as no B cell-specific marker used to allow for the 
differentiation between B and T cells.
The top panel of Figure 12 shows the MPC11 control cells that were not stained 
with PKH26 dye. The Day 0 cells are expected to have the highest intensity of PKH26 
dye since each cell contains more dye than it would if it had divided. There is not a 
noticeable change in PKH26 intensity between Day 2 and Day 3, but by Day 4 there is a 
cell population that contains a lower intensity of PKH26 and more proliferating cells. A 
histogram of the cells from Day 0, 2, and 3 is seen in Figure 13. The histogram depicts 
the results seen in the contour plots, with Day 0 showing the highest PKH26 intensity and 
Day 2 and 3 cells decreasing in intensity. The histogram shows separation of the peaks 
for each day and clearly shows that the cells were proliferating between Day 0 and Day 3.
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MPC11 
PKH26 vs. FSC 
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Figure 12. PKH26 intensity in mouse spleen cells: contour plots. Analysis o f cell 
proliferation in fixed and permeabilized M PC11 cells using PKH26 tracking dye. 
Contour plots from one-color flow cytometry using PKH26 tracking dye and cell size 
(FSC). One representative experiment shown here. C= Control, D= Day.
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Figure 13. PKH26 intensity in MPC11 cells: histogram. Analysis o f cell proliferation in fixed 
and permeabilized M PC11 cells using PKH26 tracking dye. Histograms o f PKH26 tracking dye 
on Day 0 (Dotted Black Line), Day 2 (Red Line), and Day 3 (Green Line). One representative 
experiment shown here.
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Anterior kidney cells were stained with PKH26 tracking dye, LPS-activated, and 
placed in culture. The cells were collected every 24 hours for six days. Figure 14 shows 
the contour plots for the PKH26 staining intensity and cell size (FSC). There are three 
distinct populations of different cell size and PKH26 intensity seen by Day 3 in culture, 
but there is no clear pattern seen in proliferation in terms of percent proliferating cells. 
The cells with the highest PKH26 intensity are also the largest cells, suggesting that they 
are plasmablasts or proliferating T cells. The cells with the lowest PKH26 intensity are 
also the smallest cells, suggesting that these cells are no longer dividing. These cells may 
be pre-B II cells, which do not proliferate and are smaller than the earlier B cells (pro-B 
and pre-B I cells).
Trout spleen cells were collected and analyzed using one-color flow cytometry as 
described above for the anterior kidney cells (Figure 15). There are no major differences 
seen in PKH26 staining intensity over the 6-day culture period. On Days 1 -6 we see a 
large population of cells with a high PKH26 intensity. These cells are most likely cells 
that are preparing to divide, however, we do not see a large amount of proliferation over 
the 6-day activation period. We also see a population of small cells that have a low 
PKH26 intensity that appear by Day 1-2. This population of cells is no longer 
proliferating and seems to decrease after Day 2 in culture.
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Anterior Kidney 
PKH26 vs. FSC 
Day 1-6
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Figure 14. PKH26 intensity in trout anterior kidney cells. One-color flow cytometry 
using PKH26 tracking dye and cell size (FSC) on fixed and permeabilized trout anterior 
kidney cells over a 6-day LPS-activation period. Lines separate populations based on 
PKH26 staining intensity. One representative experiment shown here.
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Trout Spleen
PKH26 vs. FSC
Day 1-6
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Figure 15. PKH26 intensity in trout spleen cells. One-color flow cytometry using PKH26 
tracking dye and cell size (FSC) on fixed and permeabilized trout spleen cells over a 6-day 
LPS-activation period. One representative experiment shown here.
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The PKH26 tracking dye gives us the ability to track cell proliferation over time. 
As the cells divide, there is a decrease in the PKH26 intensity per cell and we saw this in 
both the MPC11 cells and the trout anterior kidney and spleen cells. However, the 
patterns of proliferation are not clear in this study, with variation in intensity seen from 
one day to the next.
BrdU incorporation analyzed through one-color flow cytometry revealed 
proliferating cells in the MPC11 cell line, mouse spleen cells, and trout anterior kidney 
and spleen cells. While small populations of proliferating cells were seen using the 
PKH26 tracking dye and c-Myc with one-color flow cytometry in all systems, the 
populations were not clearly separated from the population of non-proliferating cells. The 
BrdU incorporation method showed strong separation between the proliferating and non­
proliferating populations in the MPC 11, mouse spleen, and trout anterior kidney and 
spleen cells, making it an ideal marker for tracking proliferation in these systems and for 
further use in investigating B cell proliferation in the trout immune tissues.
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3.2. Flow cytometric analysis of freshly isolated trout immune tissues
Based on previous work from our lab [108, 109] we hypothesized that the 
majority of lymphocytes in the trout spleen and blood before LPS-activation are 
resting, mature B cells with the phenotype: BrdU-/Pax-5+/Membrane IgM+/RAG- 
1-/Secreted IgM-/Total IgM+/Xbp-l+/-. In contrast, this work suggests that the 
kidney is a complex organ, with multiple B cell populations present in freshly isolated 
samples from both the anterior and posterior regions [108, 109]. The anterior kidney 
is the primary immune organ and site for B cell development and maturation [107]. 
We hypothesized that fresh cells from the anterior kidney would contain a population 
of developing B cells with the phenotype: BrdU+/Pax-5+/RAG-l+/Membrane 
IgM-/Secreted IgM-/Total IgM-/Xbp-l+. In addition, we hypothesized that the 
anterior kidney provides a storage site for antibody secreting cells (ASC) with the 
phenotype: BrdU+ or -/Pax-5+ or -/RAG-1-/Membrane IgM+ or -/Secreted IgM++/ 
Total IgM+ or ++/ Xbp-1+ or ++. The posterior kidney is thought to be a secondary 
immune organ, providing a site for antigen interaction for B cells. We hypothesized 
that freshly isolated cells from the posterior kidney would contain a mixture of resting 
and activated B cells as well as a small population of Ig secreting cells.
In order to analyze the profiles of B cell populations in the spleen, blood, and 
kidney of the rainbow trout, fresh, unstimulated trout cells were harvested, fixed and 
permeabilized, and stained with fluorescent antibodies. Analysis was done using two- 
color flow cytometry. Combinations of BrdU incorporation and Membrane IgM, Pax- 
5, RAG-1, Secreted IgM, Total IgM, and Xbp-1 fluorescent antibodies were used.
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When determining the relative frequency of each population we can begin to define 
the “B cell profiles” of freshly isolated trout spleen, blood, and kidney cells.
FSC and SSC. As described earlier (see section 3.1), dotplots were made in order to 
correctly gate the lymphocyte population located within our heterogeneous cell 
samples. Figure 16A shows the dot plots, with FSC and SSC as the parameters, for 
the spleen, blood, anterior kidney, and posterior kidney for fresh Day 0 cells. Each 
dot on the dot plot represents one cell. Figure 16B shows the same dot plots with a 
gate around a population that contains the lymphocyte population. Mature 
lymphocyte populations typically have low FSC and low SSC and this is an abundant 
population in the spleen. The lymphocyte population in the blood consists of two 
separate populations. Both have low SSC and low FSC, but one population has 
slightly higher FSC than the other. These populations are seen In Figure 16A as two 
circles in the lymphoid population of the blood dot plot. The lymphocyte population 
in both the anterior and posterior kidney is made up of cells of different size and 
complexity as seen by the increase in FSC and SSC of the population. The population 
spans from cells with low FSC and low SSC to cells with high FSC and high SSC. 
This would be expected in the anterior and posterior kidney since we hypothesized 
that they both are made up of a mixture of B cell populations. The black arrows in 
Figure 16B point out the cellular debris in each sample, which has very low FSC 
(size), and is not included in the gate. A population with low FSC and high SSC 
represent red blood cells, which were also excluded from analysis (Fig. 16B, red 
arrows).
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Proliferation. In order to determine the frequency of proliferating B cells in the trout 
immune tissues, we looked at BrdU incorporation and membrane IgM expression in 
Day 2 cells. The ratio of resting IgM+ B cells (BrdU-, mem IgM+) to plasmablasts 
(BrdU+, mem IgM+) can be seen in Figure 17. Day 2 cells were used in this analysis 
because BrdU incorporation cannot be measured in fresh Day 0 cells. The cells need 
to be grown in the presence of BrdU for at least 18 hours for detectable BrdU 
incorporation to occur. We chose to collect samples once a day for the anterior and 
posterior kidney and every other day for the spleen and blood. Because of this 
collection pattern, we did not have Day 1 samples for each tissue and had to use Day 
2 samples, which we collected for each tissue, for our analysis of BrdU incorporation. 
The largest population of proliferating IgM+ B cells is seen in the anterior kidney 
(1.2%) with smaller populations seen in the spleen and posterior kidney (<1%). These 
cells are most likely plasmablasts. Very low levels of proliferation are detected in the 
blood any time during the 10-day LPS-activation period of the blood. The spleen and 
blood contain the highest number of resting B cells (41% and 21%, respectively), 
which is hypothesized to be the majority of the B cell population in these tissues on 
Day 0.
Pax-5 and Membrane IgM. Pax-5 expression is seen in pro- and pre-B cells and 
throughout B cell maturation, but it is not expressed in plasma cells. The staining 
patterns for Pax-5 and membrane IgM provide information about the presence of 
(im)mature, resting B and early activated B cells in each of the tissues. A
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representative experiment of the relationship between Pax-5 and membrane IgM 
staining intensity in fresh Day 0 cells from each tissue is seen in Figure 18. The 
highest percentage of Pax-5+, membrane IgM+ cells is seen in the spleen (33%) and 
the blood (21%). While smaller populations, with low levels of Pax-5, were seen in 
the anterior (13%) and posterior kidney (5.5%). These cells are most likely resting B 
or early activated B cells. We expect to see high percentages of these cells in the 
spleen and blood on Day 0, based on previous work from our lab [108]. The highest 
Pax-5 and membrane IgM staining intensities are seen in the blood lymphocytes, 
suggesting that there are higher levels of Pax-5 and Membrane IgM per cell. This 
population of Pax-5+, Membrane IgM+ cells does not change throughout the anterior 
or posterior kidney culture period, as Pax-5 levels are low in this tissue (further 
discussed in Chapter IV), but interesting patterns develop at later time-points in the 
spleen and blood as discussed later.
RAG-1 and Membrane IgM. RAG-1 is involved in Ig gene rearrangement. In 
mammals, RAG-1 is expressed in pro-B, pre-B, and some immature and activated B 
cell populations [67, 87]. Figure 19 shows the co-expression of RAG-1 and 
membrane IgM in Day 0 cells for each tissue. The top right panel in each contour plot 
shows the cells that are expressing RAG-1 and membrane IgM. This population is 
most clearly seen in the spleen, and most likely represents activated B 
cells/plasmablasts. We do not see a similar pattern in the Day 0 cells from the blood 
or the kidney. This population is less than 1% in each tissue and does not change in 
the spleen, blood, or kidney after LPS activation and will be further discussed below.
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Secreted IgM and Membrane IgM. The expression patterns of secreted IgM and 
membrane IgM revealed the presence or absence of antibody secreting cells (ASC), 
either plasmablasts or plasma cells, in each tissue on Day 0. The right side of each 
contour plot in Figure 20 shows the cells that are secreting IgM. There is a very low 
frequency of IgM secretion in the spleen or blood in fresh Day 0 cells (<1%). The 
anterior and posterior kidney have a higher frequency of IgM secreting cells on Day 
0, considering that much fewer B cells reside in these tissues. Interestingly, the blood
contains a unique population of IgM secreting, Membrane IgM— cells on Day 0 (see
box).
Xbp-1 and Membrane IgM. Xbp-1 is expressed in early developing B cells (pro- 
and pre-B) and late activated B cells, plasmablasts, and plasma cells, with the highest 
levels of expression seen in plasma cells [76, 77, 91]. The co-expression of Xbp-1 
and Membrane IgM identified populations of resting B and activated B 
cells/plasmablasts. In Figure 21 the staining patterns of Xbp-1 and membrane IgM in 
fresh Day 0 cells are shown for each tissue. Cells expressing intermediate levels of 
Xbp-1 and high levels of membrane IgM are most likely mature, resting B cells (Xbp- 
1 +/-, Membrane IgM+) while cells with higher Xbp-1 expression are most likely 
activated B cells/plasmablasts (Xbp-1+, Membrane IgM+). A small population of 
activated B cells is seen in each tissue on Day 0 (see arrow). The main cell population 
that is Xbp-1+ /- and Membrane IgM+ is most likely mature, resting B cells, and we 
see a large number of these cells in both the spleen and blood, as expected. There is a
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small population of cells in the blood that are Xbp-1 ++, Membrane IgM- (see box), 
which suggests that these are most likely plasma cells.
Xbp-1 and Total IgM. The co-expression of Xbp-1 and Total IgM identified 
populations of resting B cells and activated B cells/plasmablasts and plasma cells. 
Figure 22 shows the relationship between Xbp-1 and Total IgM staining intensity in 
Day 0 cells from the spleen, blood, and kidney. The top box in each contour plot 
contains the IgM secreting B cells (Xbp-1 ++, total IgM ++) while the lower box 
contains the resting IgM+ B cells, which express lower levels of both Xbp-1 and total 
IgM (Xbp-1+/-, total IgM+). The spleen and blood have the highest percentage of 
resting IgM+ B cells on Day 0 (42% and 20%, respectively), while the anterior 
kidney has the highest percentage of IgM secreting B cells on Day 0 (6.5%). The 
anterior kidney has the lowest ratio of resting B to plasma cells on Day 0 (1.75) 
followed by the posterior kidney (2.48), spleen (16), and blood with the highest ratio 
(40). In agreement with our hypothesis, we have show that there is a higher number 
of IgM secreting cells present in the kidney on Day 0.
Based on the data presented in this section we can see that the B lymphocyte 
population in the spleen and blood on Day 0 consists mainly of resting B cells, in 
agreement with previous work from our lab. The levels of cell proliferation detected 
in fresh cells from the spleen and blood are very low, as expected. The anterior and 
posterior kidney, in agreement with our hypothesis, contain a mixture of B cell 
populations. The anterior kidney contains the largest population of proliferating B
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cells among the four tissues. Pax-5 levels are low in both the anterior and posterior 
kidney, and both tissues were the sites of highest IgM secretion with low numbers of 
resting B cells, as expected for unstimulated anterior and posterior kidney cells.
3.3. Analysis of ex  vivo  LPS-activation on trout immune tissues using two-color 
flow cytometry
Total trout immune cells were stimulated with LPS in culture and analyzed by 
two-color flow cytometry as before. Combinations of BrdU incorporation, Membrane 
IgM, Pax-5, RAG-1, Secreted IgM, Total IgM, and Xbp-1 fluorescent antibodies were 
used.
3.3.1. Spleen
Earlier work suggests that the spleen acts as a secondary lymphoid organ in 
the trout, providing a site where B cells encounter antigen and become activated [8, 
107, 108, 109]. Hence, we expect to see changing frequencies of activated B cells, 
plasmablasts and plasma cells after LPS-activation in this tissue. We hypothesized 
that as a result of LPS-activation, we would see a decrease in the frequency of resting 
B cells and an increase in the frequency of activated B cells, plasmablasts, and/or 
plasma cells.
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Pax-5 and Membrane IgM. As described in the introduction (Chapter I), Pax-5 is 
first expressed in early developing B cells (pro-B). Its expression is seen throughout 
B cell development and maturation and is lost in plasma cells [1]. The combination of 
Pax-5 and Membrane IgM provided us with the frequency of resting or activated B 
cells during LPS activation. Figure 23 shows the relationship between Pax-5 and 
Membrane IgM staining intensity in Day 0, Day 4, and Day 8 spleen cells from four 
separate experiments. The Day 0 cells show a different pattern in each experiment 
with two cell populations in the 1/28/09 experiment, three populations in the 2/19/09 
experiments, and four populations in the 3/25/09 experiment. Each experiment shows 
a different pattern without stimulation, but after LPS activation, similar populations 
are seen in all experiments, with variation as to which day those populations are 
induced.
Figure 23 shows the contour plots for Pax-5 and Membrane IgM expression 
with a schematic for interpreting the contour plots. The Pax-5 low (+/-), Membrane 
IgM+ cells are in Box A, the Pax-5+, Membrane IgM+ cells are in Box B, and the 
Pax-5+, Membrane IgM - cells are in Box C. The Pax-5 low (+/-) and Membrane 
IgM+ population (Figure 23, Box A) varies greatly between experiments. These cells 
are most likely activated IgM+ B cells, but may also be resting IgM+ B cells. This 
population is present on Day 0 in the 1/28/09 experiment, but then lost by Day 4. The 
same population is not seen on Day 0 in the 2/19/09 experiments, but is induced by 
Day 8. In the 3/25/09 experiment, this population is seen on Day 0, Day 4, and Day 8. 
This population of activated IgM+ B cells varies but is induced in all experiments by
81
Spleen
Pax-5 vs. Membrane IgM
Day 0, Day 4, Day 8
1/28/09 2/19/09A 2/19/09B 3/25/09
A B
C
Figure 23. Pax-5 and Membrane IgM expression in trout spleen cells: contour plots. Two-color 
flow cytometry using Pax-5 and Membrane IgM on fixed and permeabilized spleen cells over a 10- 
day LPS-activation period. Three representative days shown here: Day 0, Day 4, and Day 8. A. 
Contour plots from four independent experiments. B. Schematic o f cell populations in part A. Box A: 
Pax-5 low (+/-)/Mem lgM+ cells; Box B: Pax-5+/Mem IgM+ cells; Box C: Pax-5+/Mem IgM- cells.
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Figure 24. Pax-5 and Membrane IgM expression in trout spleen cells: line graphs.
Analysis o f Pax-5 and Membrane IgM expression in spleen cells over a 10-day LPS- 
activation period. A. Line graph o f Pax-5 low (+/-)/Mem IgM+ cells. B. Line graph of 
resting IgM+ B cells (Pax-5+/Mem IgM+). C. Line graph o f IgD+ or IgT+ B cells or pro- 
B cells (Pax-5+/Mem IgM-). Results shown from four or five independent experiments. 
Cells pooled from 3-5 fish in each experiment.
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Day 2, with a peak seen between Day 6 and Day 8 as shown in Figure 24A.
A large population of Pax-5+, Membrane IgM+ cells is seen in each 
experiment on Day 0, Day 4, and Day 8 (Figure 23, Box B). These are most likely 
resting B cells. This population increases slightly from Day 0-2 (22-32%) followed 
by a gradual decrease after Day 4 in culture from 20-25% at Day 4 to 7-12% on Day 
10 (Figure 24B).
Finally, a minor population of Pax-5+, Membrane IgM- cells is seen in each 
experiment (Figure 23, Box C). These cells may be IgD+ or IgT+ B cells or possibly, 
but less likely, pro-B cells. There is a general decrease in this population over the 10- 
day LPS-activation period from 9-14% on Day 0 to 2-4% on Day 10 (Fig. 24C).
RAG-1 and Secreted IgM. The co-expression of RAG-1 and Secreted IgM identified 
a population of IgM secreting activated B cells or plasmablasts. Figure 25 shows two 
representative experiments of the relationship between the RAG-1 and secreted IgM 
staining intensity in Day 0 and Day 8 spleen cells. This combination was repeated for 
a total of six experiments. This figure shows that LPS induces a splenic B cell 
population that expresses RAG-1 and secretes IgM. The cells within this population 
show increased levels of both secreted IgM and RAG-1 by Day 8 with variation seen 
between experiments. In the 3/25/09 experiment, there is an increase in the number of 
cells with this phenotype, from 2.73% on Day 0 to 14% on Day 8 (see boxed region)
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Spleen
RAG-1 vs. Secreted IgM
Day 0 and Day 8
3/25/09 5/22/09
 ►
RAG-1
Figure 25. RAG-1 and Secreted IgM expression in trout spleen cells. Two-color flow 
cytometry using RAG-1 and Secreted IgM on fixed and permeabilized spleen cells over a 10- 
day LPS-activation period. Day 0 and Day 8 shown here. Results from 2 representative 
experiments. Experiment repeated five times. Box: Induced RAG+/Sec IgM+ population. 
Arrow: RAG+/Sec IgM- population. C= Control, D= Day.
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and in the 5/22/09 experiment there is an increase from 1.27% on Day 0 to 10% on 
Day 8 (see boxed region). These cells are most likely plasmablasts or late activated B 
cells. Also of interest is a population that is present on Day 0 and Day 8 in both 
experiments that is RAG-1+ but secreted IgM- (arrow).
Proliferation. The plasmablast population in the spleen was best defined by looking 
at BrdU incorporation. When combined with Pax-5, we were able to measure the 
frequency of proliferating B cells in this tissue. These cells are most likely 
plasmablasts but may also be pre-B cells. This population peaks between Day 4 and 
Day 6 in culture (Fig. 26A). A population of Membrane IgM+ plasmablasts (Fig. 
26B) and IgM secreting plasmablasts (Fig. 26C) are also seen to peak between Day 4 
and Day 6. All three populations of proliferating B cells decrease after Day 6 in the 
10-day LPS-activation period. The 1/28/09 experiment shows a different expression 
pattern from the other three experiments with BrdU incorporation and Pax-5 or 
Secreted IgM expression. Throughout this work we observed that this experiment 
displayed patterns different from all other experiments regardless of marker 
combination. This suggests that the fish used in this experiment may have been 
immune-challenged prior to our using them, and therefore we would expect to see 
different expression patterns.
Xbp-1 and Membrane IgM. The staining patterns of Xbp-1 and Membrane IgM 
allowed for the identification of resting B cells and activated B cells/plasmablasts and 
plasma cells. Figure 27 examines these patterns in spleen cells over a 10-day LPS-
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Figure 26. BrdU incorporation and Pax-5/Membrane IgM/Secreted IgM 
expression in trout spleen cells. Analysis o f B cell proliferation in fixed and 
permeabilized spleen cells over a 10-day LPS-activation period. A. BrdU+/Pax-5+ 
proliferating B cells. B. BrdU+/Mem IgM+ plasmablasts. C. BrdU+/Sec IgM+ 
plasmablasts. Results from five or six independent experiments. Cells pooled from 
3-5 fish in each experiment.
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activation period. There is a clear decrease seen in the frequency of the resting B cell 
population (Xbp-1+/-, Membrane IgM+) from Day 0-10 (Fig. 27A), while the 
frequency of activated B cells/plasmablasts (Xbp-1+, Membrane IgM+) peaks around 
Day 6 in culture then decreases slightly through Day 10 (Fig. 27B). Figure 27C shows 
a two vertical axis graph of the B cell populations seen in parts A and B of Figure 27. 
This graph allows for the visualization that while the resting B cell population is 
decreasing in frequency, the activated B cell/plasmablast population begins to 
increase in frequency and peak at Day 6 in culture. The 5/22/09 experiment does not 
exhibit this same pattern, and this is addressed in Chapter IV.
Xbp-1 and Total IgM. The relationship between the Xbp-1 and total IgM staining 
patterns in LPS-activated spleen cells is shown in Figure 28. The resting B cell 
population (Xbp-1+/-, Total IgM+) decreases over the 10-day LPS-activation period 
(Fig. 28 A). The number of activated B cells (Xbp-1+, Total IgM+) peaks between 
Day 2 and Day 4 and decreases through Day 10 (Fig. 28B) while the 
plasmablast/plasma cell (Xbp-1++, Total IgM++) population clearly increases 
through Day 10 (Fig. 28C). Figure 28D shows the two vertical axis graph for the 
populations seen in Figure 28 parts B and C. The relationship between the activated B 
cells and the plasmablast/plasma cell populations is clear, with the activated B cell 
population decreasing in frequency over time while the plasmablast/plasma cell 
population increases in frequency over time.
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Figure 27. Xbp-1 and Membrane IgM expression in trout cells. Two-color flow 
cytometry using Xbp-1 and Membrane IgM on fixed and permeabilized spleen cells 
over a 10-day LPS activation period. A. IgM+ resting B cells (Xbp-1 +/-/M em  
IgM+). B. IgM+ activated B cells or plasmablasts (Xbp-1+/Mem IgM+). Results 
shown from four independent experiments. Repeated five times total. Cells pooled 
from 3-5 fish in each experiment.
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Figure 27C. Xbp-1 and Membrane IgM expression in trout spleen cells: two-vertical axis 
graphs. Analysis of Xbp-1 and Mem IgM in spleen B cells. Two-vertical axis graphs shown for 
four independent experiments. Repeated a total of five times. Cells pooled from 3-5 fish in each 
experiment. Solid line: resting B cells (X bp-1+/-/M em  IgM+). Dashed Line: Activated B cells 
or plasmablasts (Xbp-1+/Mem IgM+).
90
A.
CUD
c
<D
Q l
B.
-o<u
<3
<U
Ql
CQ
Spleen
X bp-l+/-/Total lgM+ Cells
50
40
=  30<u
m 20
8 100 2 4 6
Days Post-Activation
Spleen 
Xbp-l+/Total lgM+ Cells
10
■1/28/09 
■ 2/19/09A  
2 /1 9 /0 9 B
■1/28/09
•2/19/09A
2/19/09B
Days Post-Activation
c. Spleen Xbp-l++/Total lgM++ Cells
6
5
4
3
2
1
0
0 2 6 8 104
■1/28/09
•2/19/09A
2/19/09B
</)■*-»(/)
“S "555 u
“ c TO £
“■ « C o-<U w U O<uQ.
Days Post-Activation
Figure 28. Xbp-1 and Total IgM expression in trout spleen cells. Two-color flow 
cytometry using Xbp-1 and Total IgM on fixed and permeabilized spleen cells over a 
10-day LPS activation period. A. IgM+ resting B cells (Xbp-1+/-/Total IgM+). B. 
IgM+ activated B cells (Xbp-1+/Total IgM+). C. Plasmablasts or plasma cells (Xbp- 
l++/Total IgM++). Three representative experiments shown. Repeated five times 
total. Cells pooled from 3-5 fish in each experiment.
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Figure 28D. Xbp-1 and Total IgM expression in trout spleen cells: two-vertical 
axis graphs. Analysis o f Xbp-1 and Total IgM in spleen B cells. Two-vertical axis 
graphs shown for three independent experiments. Experiment repeated four times. 
Solid line: resting B cells (Xbp-1 +/-/Total IgM+). Dashed Line: Plasmablasts or 
plasma cells (Xbp-1++/Total IgM+). Results shown from three representative 
experiments. Repeated five times total. Cells pooled from 3-5 fish in each 
experiment.
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The data presented in this section identified changes in populations of resting 
B cells, activated B cells, plasmablasts, and plasma cells in the spleen after LPS 
activation. The resting B cell population decreases over the 10-day activation period, 
while the populations of activated B cells, plasmablasts, and plasma cells increase. 
We have shown that the majority of B cells in the trout spleen are resting B cells that 
become activated after stimulation with LPS. Small populations of plasmablasts and 
plasma cells were seen at later time points in the 10-day LPS activation period. The 
antibody combinations of RAG-1/Membrane IgM and Secreted IgM/Membrane IgM 
were also investigated, but no clear changes were seen in the B cell populations after 
LPS activation. Further investigation with these antibody combinations is necessary 
to gain more information about the B cell populations in the trout spleen after LPS 
activation.
3.3.2. Blood (PBL)
Teleost blood may act as a “transport tissue”, bringing immune cells from one 
tissue to another. Because of this function, the blood likely contains a mixture of 
immune cells, including various types of B cells at different stages of development 
and activation. Previous work from our lab suggests that the blood contains resting 
and activated B cells and plasmablasts, with few to no plasma cells [108]. Here we 
hypothesized that after LPS activation in culture, resting B cells in the blood become 
activated early on but that this population may die in culture with new populations of
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activated B cells rising from the resting B cells over time. We examined BrdU 
incorporation in three separate experiments. No detectable levels of BrdU 
incorporation were seen in any of the immune cells in the blood (data not shown), 
suggesting that no proliferating cells exist or survive in the blood cultures. To better 
understand the types of B cells found in the blood, cells were analyzed by two-color 
flow cytometry.
RAG-1 and Secreted IgM. In order to investigate the presence of activated B cells in 
the blood, levels of RAG-1 and Secreted IgM were measured. Figure 29 examines the 
staining patterns of RAG-1 and secreted IgM in Day 0 and Day 8 blood B cells in 
three separate experiments. When looking at the fresh Day 0 cells, we see very few 
RAG-1+, IgM secreting cells, suggesting that very few of these cells are present in 
healthy trout blood. By Day 8 in culture there is induction of a RAG-1 expressing, 
IgM secreting population of B cells (see boxed region). These cells are most likely 
late activated B cells or pre-plasma cells. Of particular interest is a RAG-1+, Secreted 
IgM- population present in two of the experiments (arrow). This population is also 
seen in the spleen with this antibody combination.
Secreted IgM and Membrane IgM. A population of B cells that produces both 
membrane and secreted IgM was seen in the blood. This population of activated B or 
B-l cells (not plasmablasts, as no cells incorporate BrdU in the blood) peaks between 
Day 2 and Day 4 and then decreases through Day 10 (Fig. 30A). The blood also 
contains a population of IgM secreting cells that gradually decreases over the 10-day
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Blood (PBL) 
RAG-1 vs. Secreted IgM 
Day 0 and Day 8
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Figure 29. RAG-1 and Secreted IgM expression in trout blood cells. Two-color flow 
cytometry using RAG-1 and Secreted IgM on fixed and permeabilized blood (PBL) cells 
over a 10-day LPS-activation period. Day 0 and Day 8 shown here. Results from three 
representative experiments. Experiment repeated five times. Box: Induced RAG+/Sec IgM+ 
population. Arrow: RAG+/Sec IgM- population.
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Figure 30. Secreted IgM and Membrane IgM expression in trout blood cells.
Two-color flow cytometry using Secreted IgM and Membrane IgM on fixed and 
permeabilized blood cells over a 10-day LPS activation period. A. Activated B or 
B-l cells (Sec IgM+/Mem IgM+). B. IgM secreting B cells (Sec IgM+/Mem IgM- 
). Results from three representative experiments. Repeated five times total. Cells 
pooled from 3-5 fish in each experiment.
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LPS-activation period (Fig. 30B). Figure 30C shows the contour plots of the secreted 
IgM+, membrane IgM+ population to visually see the shift in the amount of IgM 
secretion per cell. There appears to be an increase in membrane IgM intensity 
followed by an increase in secreted IgM intensity, with more IgM secreted over time.
Pax-5 and Membrane IgM. The combination of Pax-5 and Membrane IgM 
identified resting B or early activated B cells in our samples. Figure 31 depicts the 
relationship between Pax-5 and membrane IgM staining intensities in blood B cells 
over a 10-day LPS-activation period. As expected, the main B cell population consists 
of resting B cells (Pax-5+, membrane IgM+) which peaks between Day 2 and Day 4 
(Fig. 31 A) while a moderate population of membrane IgD+, membrane IgT+, or 
possibly pro-B cells (Pax-5+, Membrane IgM-) is seen to generally decrease after 
Day 2 of the LPS-activation period (Fig. 3 IB). There are no resting B cells of any 
isotype present on Day 0 in the 1/28/09 experiment. There is induction of a small 
population of membrane IgM+ resting B cells by Day 2 in culture but it then 
decreases. By Day 10 we see very few resting B cells independent of isotype (IgM, 
IgD, or IgT) and it may be that these cells become activated by Day 10 in culture.
Xbp-1 and Membrane IgM. The co-expression of Xbp-1 and membrane IgM in a 
cell population allows for the identification of a population of activated B cells as 
cells increase their Xbp-1 levels after activation. Figure 32A visually shows the 
frequency of a membrane IgM+ population that increases between Day 0 and Day 8. 
There is an increase in Xbp-1 intensity over the 10-day period, suggesting that these
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Figure 31. Pax-5 and Membrane IgM expression in trout blood cells.
Two-color flow cytometry using Pax-5 and Membrane IgM on fixed and 
permeabilized blood cells over a 10-day LPS activation period. A. IgM+ resting 
B cells (Pax-5+/Mem IgM+). B. IgD+ or IgT+ or pro-B cells (Pax-5+/Mem 
IgM-). Three representative experiments shown. Repeated a total o f five times. 
Cells pooled from 3-5 fish in each experiment.
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cells become activated in culture. We see a shift from IgM+ resting B cells to IgM+ 
activated B cells between Day 2 and Day 4 in culture based on the increase in Xbp-1 
intensity. Figure 32B shows the population of IgM+, Xbp-1 + /- resting B cells 
peaking between Day 0 and Day 2 and then gradually decreasing through Day 10 in 
culture, while the IgM+, Xbp-1 + activated B cells population is seen to peak between 
Day 2 and Day 4 in culture (Fig. 32C), but this population varies between 
experiments.
Xbp-1 and Total IgM. A population of resting B cells (Xbp-1+/-, Total IgM+) 
gradually decreases over the 10-day LPS-activation period (Fig. 33A), presumably 
because such cells become activated and shift from Xbp-1+ /- to Xbp-1 + during this 
time. Figure 33B shows a population of activated B/pre-plasma cells (Xbp-1++, total 
IgM+). This population peaks on different days depending on the fish, but it shows 
that LPS activated the cells in culture. Similar patterns for these populations are also 
seen in the spleen. Figure 33C shows the 2 vertical axis graph of the populations seen 
in Figure 33 parts A and B, and the patterns between the resting B and activated B 
cell populations is clearly seen.
In agreement with our hypothesis, we saw that the majority of the B cell 
population in the blood consists of resting B cells that become activated after 
stimulation with LPS. We have shown that the number of resting B cells decreases 
while the number of activated B cells increases over the 10-day LPS activation 
period. As mentioned above, we did not see any detectable levels of BrdU
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Figure 32. Xbp-1 and Membrane IgM expression in trout blood cells: contour plots. Two- 
color flow cytometry using Xbp-1 and Membrane IgM on fixed and permeabilized blood cells 
over a 10-day LPS activation period. A. Contour plots. One representative experiment shown. 
Experiment repeated 3 times. Cells pooled from 3-5 fish in each experiment.
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Figure 32. Xbp-1 and Membrane IgM expression in trout blood cells: line 
graphs. Two-color flow cytometry using Xbp-1 and Membrane IgM on fixed 
and permeabilized blood cells over a 10-day LPS-activation period. B. IgM+ 
resting B cells (Xbp-1 +/-/M em  IgM+). C. IgM+ ASCs (Xbp-1 ++/Mem IgM+). 
Results from three representative experiments. Repeated five times. Cells 
pooled from 3-5 fish in each experiment.
101
A. Blood (PBL)
Xbp-1+/- /  Total lgM+ Cells
16</>
=35 14
°  12 CQ
10 
8 
6 
4  
2 
0
tr
6 8 100 2 4
■1/28/09
■3/25/09
>4/27/09
5/22/09
Days Post-Activation
B. Blood (PBL) 
Xbp-l++/Total |gM+ Cells
20
co
7  ”(V =
ro u
CDU C < £ (U (O
3 5—1 0J+-> L.
C  Ql01u
•1/28/09
3/25/09
5/22/09
Days Post-Activation
Figure 33. Xbp-1 and Total IgM expression in trout blood cells. Two-color 
flow cytometry using Xbp-1 and Total IgM on fixed and permeabilized blood 
cells over a 10-day LPS-activation period. A. IgM+ resting B cells (Xbp- 
l+ /-/T otal IgM+). B. IgM+ activated B or pre-plasma cells (Xbp-1 ++/Mem 
IgM+). Results from three representative experiments. Repeated five times. 
Cells pooled from 3-5 fish in each experiment.
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Figure 33C. Xbp-1 and Total IgM expression in trout blood cells: two-vertical axis 
graphs. Two-color flow cytometry using Xbp-1 and Total IgM in blood B cells over a 
10-day LPS-activation period. Two-vertical axis graphs shown for three independent 
experiments. Repeated five times. Cells pooled from 3-5 fish in each experiment. Solid 
line: resting B cells (Xbp-1+/-/Total IgM+). Dashed Line: Late activated B or pre­
plasma cells (Xbp-1++/Total IgM+).
103
incorporation in the blood lymphocytes, suggesting that proliferating cells are not 
induced or do not survive in culture. A small population of IgM secreting cells was 
seen in the blood, suggesting that there are very low numbers of plasma cells in this 
tissue as seen in previous work from our lab. The lack of proliferation seen in this 
study is unexpected, considering the presence of activated B cell and pre-plasma cell/ 
IgM-secreting cell populations (for further discussion see Chapter IV). The RAG-1 
and Membrane IgM antibody combination was also investigated, but no change was 
seen in the population after activation with LPS and further work needs to be done 
with this combination in the blood.
3.3.3 Anterior Kidney
The anterior kidney serves as the primary immune tissue of the rainbow trout 
[ 107] and we expected to see a large population of developing B cells characterized 
as Pax-5+/RAG-l+/Membrane IgM-/Secreted IgM-/Total IgM-/Xbp-l+ present in 
this tissue. In addition, the anterior kidney is thought to store antibody-secreting cells 
(ASC) and we predicted that we would see IgM secreting and Xbp-1 ++ cells here 
after LPS activation. Developing B cells are insensitive to LPS activation and if the 
main population of B cells is developing B cells, then we would expect to see low 
levels of activated B cells and ASCs in the anterior kidney. The anterior kidney may 
also contain a population of developing non-B immune cells among the populations 
of B cells.
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Proliferation. The anterior kidney is hypothesized to contain a population of 
proliferating, developing B cells (pre-B). Figure 34 shows the relationship between 
BrdU incorporation and membrane IgM staining intensity and the contour plot for the 
population of proliferating B cells. The number of proliferating mature B cells 
(BrdU+, membrane IgM+; Figure 34, Box B) peaks between Day 4 and Day 5, while 
the frequency of non-proliferating mature B cells (BrdU-, membrane IgM+; Figure 
34, Box A) remains fairly constant with a slight peak around Day 4.
Analysis with two-color flow cytometry identified a population of 
proliferating, developing B cells in the anterior kidney after LPS activation. Pax-5, 
Secreted IgM, and Xbp-1 levels were low in this tissue. The combinations of RAG- 
1/Membrane IgM and RAG-1/Secreted IgM showed no change in the cell populations 
over the 7-day LPS activation period. When looking at the co-expression of Xbp-1 
and Total IgM, we saw a population that is high for both markers and would most 
likely represent plasma cells (ASC), but there was variation among experiments and 
the population will need to be further investigated. Based on the markers we used in 
this study, it appears that the B cell populations do not change in the anterior kidney 
after LPS activation. These are preliminary results and further investigation of the 
anterior kidney with these markers and other developing B cell markers is necessary 
to begin to identify the B cell profile of the anterior kidney.
106
3.3.4. Posterior Kidney
The posterior region of the kidney contains both immune and renal cells. This 
tissue functions mainly as a renal tissue, aiding in the removal of metabolic waste 
from the fish [68]. Immune cells are in the minority in the posterior kidney and there 
is little known about the B cell profile of this tissue. It has been hypothesized the 
posterior kidney may act as a secondary immune organ and that populations of 
activated B cells, plasmablasts, and plasma cells are found in this tissue, but there 
may also be populations of developing B cells.
Proliferation. The incorporation of BrdU into cells allowed for the identification of 
proliferating cells. Figure 35 shows the relationship between BrdU incorporation and 
secreted IgM staining intensity in Day 1 posterior kidney cells. The B cells that are 
secreting IgM and not proliferating are gated and such cells are most likely plasma 
cells (Box A). From this antibody combination, we can see that there are very few 
(<1%) IgM secreting plasma cells in the posterior kidney. We can also see that there 
are less than 1 % IgM secreting plasmablasts on Day 1 in the posterior kidney (Box 
B).
Proliferating B cells were also observed through the co-expression of BrdU 
incorporation and Membrane IgM. Figure 36 shows the Day 2 contour plot 
highlighting the Membrane IgM+, non-proliferating B cells (Box A) and the 
Membrane IgM+, proliferating plasmablasts (Box B), with corresponding line graphs.
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BrdU vs. Secreted IgM
Day 1 Cells
BrdU
Figure 35. BrdU incorporation and Secreted IgM expression in trout posterior 
kidney cells. Two-color flow cytometry using BrdU incorporation and Secreted 
IgM markers in Day 1 fixed and permeabilized posterior kidney cells. Contour plot 
o f Day 1 cells. Box A: non-proliferating IgM secreting cells. Box B: proliferating, 
IgM secreting cells. Results from one representative experiment. Experiment 
repeated three times. Cells pooled from 3-5 fish in each experiment. C= Control, D= 
Day.
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A population of proliferating B cells was also detected using the Pax-5 and 
BrdU incorporation markers. Figure 37 shows a contour plot with a gate around the 
proliferating B cells (BrdU+, Pax-5+). This population decreases over the 5-day LPS- 
activation period.
Figure 38 compares the BrdU+/Pax-5+ (Solid Line) and BrdU+/Membrane 
IgM+ (Dashed Line) populations for each experiment in a two-vertical axis graph. In 
the 2/19/09 experiments, the number of proliferating B cells (BrdU+/Pax-5+) 
decreases while the number of plasmablasts (BrdU+/Membrane IgM+) increases. The 
populations in the 1/28/09 experiment exhibit an opposite pattern, with the 
BrdU+/Membrane IgM+ plasmablast population starting out high and then 
decreasing, while the BrdU+/Pax-5+ proliferating B cell population starts out low and 
increases through Day 4 of the 4-day LPS-activation period.
Xbp-1 and Membrane IgM. The combination of Xbp-1 and Membrane IgM allowed 
for the identification of resting B and activated B cells. Figure 39 shows the 
relationship between Xbp-1 and membrane IgM staining intensity over the 5-day 
culture period. Between 3-6% of posterior kidney cells express high Xbp-1 and are
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Figure 37. BrdU incorporation and Pax-5 expression in trout posterior 
kidney cells. Two-color flow cytometry using BrdU incorporation and Pax-5 
antibodies in Day 2 fixed and permeabilized posterior kidney cells. The box 
gates the Pax-5+ proliferating B cells. Results from one representative 
experiment. Experiment repeated three times. Cells pooled from 3-5 fish in 
each experiment. C= Control, D= Day.
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Figure 38. BrdU incorporation and Pax-5/Membrane IgM expression in trout 
posterior kidney cells: two-vertical axis graphs. Analysis o f Pax-5+ proliferating B 
cells and Membrane IgM+ proliferating B cells in the posterior kidney over a 5-day 
LPS-activation period. Line graphs representing three independent experiments. Cells 
pooled from 3-5 fish in each experiment. Solid line: BrdU+/Pax-5+. Dashed Line: 
BrdU+/Membrane IgM+.
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Figure 39. Xbp-1 and M em brane IgM expression in tro u t posterio r kidney 
cells. Analysis o f Xbp-1 +/Membrane IgM+ activated B cells/plasmablasts in fixed 
and permeabilized posterior kidney cells over a 5-day LPS-activation period. 
Results from four independent experiments. Total o f six experiments. Cells pooled 
from 3-5 fish in each experiment.
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The Membrane IgM+, non-proliferating B cell population, approximately 5-8% of all 
cells, does not appear to change over time while the population of Membrane IgM+ 
plasmablasts doubles between Day 3 and Day 4 of the 5-day LPS-activation period, 
increasing from <1% to approximately 1.5-2% of the total B cell population. 
Membrane IgM+. This population of activated B cells/ plasmablasts (Xbp-1+, 
membrane IgM+) increases overall with a subtle peak in the population around Day 2 
to 3 in culture.
Xbp-1 and Total IgM. The relationship between the staining patterns of Xbp-1 and 
Total IgM allowed for the identification of resting B and activated B cells based on a 
shift in Xbp-1 levels after activation. Figure 40 examines the relationship between 
Xbp-1 and Total IgM in the posterior kidney over a 5-day LPS-activation period. The 
contour plot for Day 0 Xbp-1/Total IgM cells highlights the resting B and activated B 
cell populations (Figure 40A, see boxes). Figure 40B looks at the two vertical axis 
graphs for the Xbp-1, Total IgM expression in the posterior kidney. A population of 
resting B cells (Xbp-1+/-, Total IgM+, solid line) is shown to increase in two 
experiments, while in a third experiment it decreases over time. The population of 
activated B cells (Xbp-1+, Total IgM+, dashed line) increases over time in all three 
experiments.
The data presented above identified populations of resting B and activated B 
cells, plasmablasts, and plasma cells in the posterior kidney. As discussed earlier, 
there is little known about the B cell profile of the posterior kidney, but in agreement
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Figure 40. Xbp-1 and Total IgM expression in trout posterior kidney cells.
Analysis o f fixed and permeabilized posterior kidney cells over a 6-day LPS-activation 
period using Xbp-1 and Total IgM. A. Contour plot o f two-color flow cytometry. Top 
box contains activated B cells and bottom box contains resting B cells. B. Line graphs 
for three independent experiments. Solid Line: Resting B cells (Xbp-1+/-/Total IgM+). 
Dashed Line: Activated B cells (Xbp-l+/Total IgM+). Experiment repeated four times. 
Cells pooled from 3-5 fish in each experiment.
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with our hypothesis, we saw resting B cells that became activated B cells after 
stimulation with LPS. We saw small populations of plasmablasts and plasma cells, 
but at very low levels (0.5-3%). The combinations of RAG-1/Membrane IgM and 
RAG-l/Secereted IgM expression were analyzed but there was no change in the 
populations. Immune cells are the minority in the posterior kidney and we are just 
beginning to identify what types of B cells are present in this tissue. Preliminary 
results were presented in this section and further investigation of this tissue is 
necessary to identify the B cell populations present in the posterior kidney after LPS 
activation.
3.4. Analysis of Total IgM levels in supernatant from LPS-activated trout B cells
Based on previous work from our lab, we hypothesized that the anterior and 
posterior kidney would have the highest levels of IgM secretion, while the spleen 
would have lower levels and the blood would have little to no IgM secretion [108, 
109]. In the spleen, blood, and kidney, low levels of IgM secretion were detected 
through two-color flow cytometry. Trout B cells were activated with LPS as part of 
the flow cytometry analysis, grown in culture for 24 (kidney) or 48 (spleen and 
blood) hours, and the supernatants were collected. To independently detect LPS- 
induced IgM secretion, ELIS As were done on the supernatants from the spleen, 
blood, and kidney B cells.
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The supernatants from the spleen B cells showed an increase in detectable 
levels of IgM secretion upon cell culturing in the presence of LPS (Figure 41 A). The 
anterior kidney showed variation between experiments, but in all experiments the 
amount of detectable IgM was lowest on Day 3 and Day 6 of the 7-day LPS- 
activation period (Figure 4 IB). In the posterior kidney, an increase in the detectable 
levels of IgM is seen after Day 1. On Day 3 in all experiments, the levels drop and 
then increase again through Day 4 or 5 (Figure 41C). In the blood, the detectable IgM 
levels increase from Day 2-10 of the LPS-activation period (Figure 4 ID). We saw 
low levels of increase in IgM secretion in each tissue over the culture period, which 
agrees with the low levels of IgM secretion seen in the two-color flow cytometry 
analysis.
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Figure 41 A. ELISA data from LPS-activated trout spleen cells. Analysis 
o f detectable IgM secretion in supernatants from LPS-activated spleen cells. 
Three independent experiments shown. Repeated a total o f 4 times. Samples 
ran in quadruplicate for each day in each experiment.
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Figure 40B. ELISA data from LPS-activated trout anterior kidney cells.
Analysis o f detectable IgM secretion in supernatants from LPS-activated anterior 
kidney cells. Three independent experiments shown. . Repeated a total o f 4 times. 
Samples ran in quadruplicate for each day in each experiment.
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Figure 40C. ELISA data from LPS-activated trout posterior kidney cells.
Analysis o f detectable IgM secretion in supernatants from LPS-activated 
posterior kidney cells. Three independent experiments shown. . Repeated a total 
o f 4 times. Samples ran in quadruplicate for each day in each experiment.
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Figure 40D. ELISA data from LPS-activated trout blood cells.
Analysis o f detectable IgM secretion in supernatants from LPS-activated 
blood cells. Three independent experiments shown. . Repeated a total o f 4 
times. Samples ran in quadruplicate for each day in each experiment.
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CHAPTER IV
Discussion
As described by Zapata et al [107], trout lack bone marrow and typical lymph 
nodes and utilize the kidney, spleen, and blood for B lymphocyte development, 
activation, and differentiation. Through this thesis project, our aim was to identify B cell 
populations within the trout anterior and posterior kidney, spleen, and blood ex vivo in 
freshly isolated and LPS-activated cells. In agreement with our hypothesis, the majority 
of the lymphocyte population in freshly isolated spleen cells consisted of resting B cells. 
After LPS-activation, we saw a decrease in the frequency of resting B cells accompanied 
by an increase in the frequency of activated B cells, plasmablasts, or plasma cells. The 
blood, like the spleen, was found to contain a large population of resting B cells in freshly 
isolated cells. As hypothesized, following LPS-activation the frequency of resting B cells 
decreased as the frequency of activated B cells increased. No proliferation was detected 
in this tissue, but a small population of low-IgM secreting ASCs was found in the blood 
both before and after LPS-activation. The anterior kidney was found to contain primarily 
a population of ASCs and developing B cells, with few resting B cells seen. However, the 
anterior kidney is a complex tissue containing various immune cells at different stages of 
development, and populations of B cells were difficult to detect in this tissue. The 
posterior kidney was found to contain a population of resting B cells that decreased in 
frequency after LPS-activation while a population of activated B cells increased in 
frequency.
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B cells were analyzed with two-color flow cytometry using combinations of BrdU 
incorporation, Pax-5, RAG-1, Membrane IgM, Secreted IgM, Total IgM, and Xbp-1 
markers. After testing various combinations of these markers, we determined that BrdU, 
Membrane IgM, Total IgM, and Xbp-1 provide the most information about the B cell 
populations in the immune tissues of the rainbow trout. The expression levels of these 
markers in resting B cells, activated B cells, plasmablasts, and plasma cells are 
summarized in Table 3.
Optimal B cell marker combinations for characterizing B cell 
activation and differentiation stages
Cell Type BrdU
incorporation
Membrane IgM Total IgM Xbp-1
Resting B — + + +/-
Activated B — + + +
Plasmablast + + ++ +
Plasma Cell — — ++ ++
Table 3. Summary o f the most informative B cell markers combinations from this thesis research. The 
BrdU, Membrane IgM, Total IgM, and Xbp-1 markers were the most successful in providing information 
about the B cell populations present in the trout immune tissues before and after LPS-activation. This table 
and the following Discussion focus mainly on the frequencies o f the resting B cell, activated B cell, 
plasmablast, and plasma cell populations, as characterized by the phenotypes presented in Table 3.
4.1. The transcription factor Xbp-1, together with Membrane IgM or Total IgM, 
provide highly reliable markers for B cell activation.
Xbp-1 is expressed in early developing B cells and during the terminal stages of B 
cell differentiation, with the highest levels of Xbp-1 expression seen in plasma cells [77, 
91]. In this thesis research, we used Xbp-1 intensity in B cell populations, in combination
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with either Membrane IgM or Total IgM expression, to measure B cell responses ex vivo. 
Spleen, blood, and posterior kidney cultures stimulated with LPS showed an increase in 
the levels of Xbp-1 protein per cell, and this phenotypic change correlates with B cell 
activation. We propose that resting B cells are Xbp-1+ /- / Membrane IgM+/ Total IgM+, 
activated B cells are Xbp-1+/ Membrane IgM+/ Total IgM+, plasmablasts are Xbp-1+/ 
Membrane IgM+/ Total IgM++, and plasma cells are Xbp-1++/ Membrane IgM-/ Total 
IgM++. As resting B cells become activated B cells, we see an increase in the amount of 
Xbp-1 protein per cell. The Xbp-1 expression levels increase further as the cells 
differentiate into ASCs.
In contrast, B cells in the anterior kidney showed no change in the levels of Xbp- 
1/Membrane IgM or Xbp-1/Total IgM expression before or after LPS-activation. This 
suggests that the majority of the B cell population in the anterior kidney consists of early 
developing B cells, which are insensitive to LPS. Interestingly, there is a population of 
Xbp-1++, Total IgM++ ASCs present in the anterior kidney in fresh Day 0 cells. 
However, this population remains unchanged throughout the 7-day LPS-activation 
period, suggesting that plasmablasts and plasma cells are insensitive to LPS, but do not 
undergo cell death during culture. In agreement with these data, ELISA data from LPS- 
activated anterior kidney cells showed no consistent change in the amount of IgM 
produced by these cells over the culture period.
In freshly isolated cells from the spleen and blood, the great majority of the B cell 
population consisted of resting B cells based on the Xbp-1+/-, Membrane IgM+ or Xbp-
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1+/-, Total IgM+ phenotype. After LPS-activation, there was an increase in the amount 
of Xbp-1 protein per cell, as the cells progressed from resting B cells to activated B cells 
(Xbp-1+, Membrane IgM+ or Xbp-1+, Total IgM+). A population of ASCs (Xbp-1++, 
Total IgM++) that was present at a low frequency (0.8-2%) in freshly isolated spleen 
cells continued to increase in frequency after LPS-stimulation. This population only 
reached a frequency of 3-5% by Day 10 of the culture period. This suggests that B cell 
activation in the trout is a longer process as compared to mammals, whose plasma cell 
population is induced by Day 4 after antigenic stimulation and reaches a frequency of 
30% at this time [91, 100]. When grown in culture, mouse cells receive one-fifth the 
amount of LPS that trout cells receive. In addition, trout cells are maintained in culture at 
18°C, while mouse cells are grown at 37°C. The cooler temperature may, in part, account 
for the difference in the timing of activation between the trout and mammalian system.
In a previous study from our lab [109], as well as in this research, we saw very low 
frequencies of both plasmablasts and plasma cells in the trout immune tissues, in 
agreement with the possibility that B cell activation may take longer in the trout.
The increase in the frequency of the ASC population is in agreement with ELISA 
data from the LPS-activated spleen cells. The ELISA data showed an increase in IgM 
production over the 10-day culture period in further support of the increasing ASC 
population in the spleen. In addition, PCR data from our lab support these data as well. 
They show an increase in the secreted IgM to membrane IgM RNA transcript ratio over 
the LPS-activation period (Day 0-7), hence at the RNA level, splenic B cells are
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producing more secreted IgM transcripts than IgM transcripts after LPS-activation (Raaj 
Talauliker, unpublished data).
In the blood, we saw a general decrease in the frequency of the resting B cell 
population over the 10-day LPS-activation period. Accompanying this was induction of 
an ASC population (Xbp-1++, Membrane IgM+/-) by Day 2 following LPS stimulation. 
This population peaked on Day 4 and decreased through Day 10 of the culture period, 
suggesting that these cells may be dying in culture, as observed through other antibody 
combinations in this study. However, a unique population of IgM-secreting, Membrane 
IgM- cells was observed in freshly isolated blood cells, suggesting the presence of 
plasma cells in this tissue. This population is highest on Day 0 and decreases in frequency 
following LPS-activation, but this population is never completely lost over the 10-day 
culture period. The loss of cells in this population suggests that these plasma cells are 
undergoing cell death after LPS-activation. It is possible that a few of these plasma cells 
survive the LPS and maintain the population or it may be that new plasma cells are 
produced that take their place.
In partial agreement with the data presented here, ELISA data from LPS-activated 
blood B cells showed an increase in IgM production over the 10-Day culture period. 
While we did not see an increase in the plasma cell/ASC population during the culture 
period, the accumulation of the antibody from the low IgM-secreting cells may be the 
reason for the increase in antibody production seen through the ELISA data. PCR data 
from our lab have shown no significant increase in the secreted IgM to Membrane IgM
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RNA transcript ratio over the LPS-activation period (Day 0-7; Raaj Talauliker, data not 
published). This suggests that B cell activation may be a slow process in blood cultures. 
Future experiments in trout blood with these markers and apoptosis markers are required 
to better understand the ASC population in this tissue.
In agreement with previous work with trout immune tissues, this study found 
resting B cells, activated B cells, and ASCs in the spleen and blood of the trout [8, 109]. 
However, this study has, for the first time, enabled the detailed analysis of B cell 
responses as defined by the frequency of activated B cell, plasmablast, and plasma cell 
populations upon LPS-induction through flow cytometry. Combinations of Xbp-1 and 
Membrane IgM or Total IgM, based on the phenotypes presented here, can be used to 
assess the immune status of fish.
4.2. BrdU incorporation can be used to identify proliferating B cells in trout 
immune tissues.
The rate of proliferation and the frequency of proliferating B cells in the trout 
immune tissues are unknown. Previous work has shown that the trout spleen, anterior 
kidney, and blood contain populations of ASCs that are sensitive to the DNA replication 
inhibitor hydroxyurea (HU), suggesting that these cells are plasmablasts [8]. An earlier 
study from our lab [108] used a percoll-gradient to identify plasmablasts (P60 layer) in 
the trout immune tissues. The kidney (anterior and posterior regions) was found to 
contain the largest number of proliferating cells, while low levels of proliferating cells
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were seen in the P60 layer of the spleen and blood. The anterior kidney was the only 
tissue to show significant proliferation in the P70 layer, which would include 
proliferating early B cells, as expected in this hematopoietic tissue [108].
Bromage et al [8] looked at total cell proliferation in the spleen, blood, and 
anterior kidney, while Zwollo et al [108] looked at percoll-purified cells. Neither study 
included a B cell specific marker to determine if the proliferating cells were B cells. This 
thesis work used BrdU incorporation in combination with the B cell-specific markers 
Membrane IgM, Secreted IgM, and Pax-5 to identify proliferating B cells in LPS- 
activated spleen, blood, and kidney cell populations. Through flow cytometric analyses, 
frequencies of proliferating B cells were determined for each of the trout immune tissues.
This study found proliferating B cells in the spleen, anterior kidney, and posterior 
kidney of the trout. Proliferating B cells were found in the spleen using all three marker 
combinations. The population of proliferating B cells that are Pax-5+ are most likely 
plasmablasts, but may also be pro- or pre-B cells. As a secondary immune organ, we 
expect the spleen to contain mostly resting B or activated B cells, plasmablasts, and 
plasma cells [8, 108, 109]. Therefore, it is less likely that the proliferating B cells in the 
spleen are developing B cells. This population peaks between Day 4 and Day 6 at about 
1%. We see variation among the experiments with this combination. This could be due to 
the variation in Pax-5 expression in this tissue (see sections 4.2 and 4.3). The variation in 
Pax-5 levels could be attributed to alternative splicing of Pax-5, which our lab has found 
in the spleen (Raaj Talauliker, data not published). If alternative isoforms of Pax-5 are
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present in the splenic B cells, then our Pax-5 (ED-1) antibody may not bind all of the 
Pax-5 expressed in those cells.
Populations of Membrane IgM+, IgM-secreting plasmablasts are found in the 
spleen. These populations peak between Day 4 and Day 6, just as the Pax-5+ proliferating 
cells did. The plasmablast population in the spleen is very small, with less than 2% of 
plasmablasts in the spleen in all cases.
The anterior kidney contained the highest frequency of proliferating B cells. The 
BrdU incorporation/Membrane IgM combination identified a population of proliferating 
IgM+ cells that peaks between Day 4 and Day 6. These cells are most likely 
plasmablasts, but could also be pre-B cells. The anterior kidney contains a population of 
ASCs, including plasmablasts, that is seen with and without LPS stimulation [8, 108]. 
Further investigation with tri-color flow cytometry including BrdU incorporation, 
Membrane IgM, and Secreted IgM or an early B cell marker, such as EBF, would allow 
for the distinction between plasmablasts and pre-B cells.
Low levels of Pax-5 and Secreted IgM were detected in the anterior kidney, and 
in combination with BrdU incorporation, we found very low frequencies of Pax-5+ 
proliferating cells and IgM secreting plasmablasts (<1% for both combinations) over the 
7-day LPS-activation period (data not shown). As discussed above, the low levels of Pax- 
5 may be attributed to alternative splicing. BrdU incorporation is strong in anterior
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kidney cells and further investigation with different Pax-5 antibodies may provide more 
information about the proliferating B cell population in the anterior kidney of the trout.
A population of plasmablasts was found in the posterior kidney using all three 
combinations. This is in agreement with previous work from our lab that found 
plasmablasts through percoll-density experiments [108]. The data from this research 
indicates that there are <1% IgM-secreting plasmablasts and Pax-5+ proliferating B cells, 
while there is a slightly higher frequency of Membrane IgM+ plasmablasts (1.5-2%) in 
the posterior kidney.
BrdU incorporation was a successful marker for cell proliferation in trout spleen, 
anterior and posterior kidney. The combination of BrdU incorporation with Membrane 
IgM proved to be the best for identifying proliferating B cells in these immune tissues. 
Proliferating B cells were identified in the spleen, anterior kidney, and posterior kidney at 
low frequencies. Trout B cells may proliferate slower than we expect and we could be 
missing the proliferative phase or there may be a low frequency of proliferating B cells in 
response to antigenic stimulation in the trout immune tissues.
The low-levels of Secreted IgM seen through flow cytometry in this study may be 
attributed to the loss of the Secreted IgM protein from the cell. As the cells are fixed and 
permeabilized, the protein may diffuse out of the cells and be lost. Future studies using 
Golgi-stop to prevent the Secreted IgM protein from leaving the Golgi apparatus, keeping
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it in the cell, may allow for better results and provide more information on the ASC 
populations, including plasmablasts, in the trout immune tissues.
BrdU incorporation was analyzed in LPS-activated blood cells as well. There was 
little to no proliferation detected (0.1%) in this tissue during the 10-day culture period. 
This is in agreement with recent work from our lab that found low levels of activated B 
cells and plasmablasts in the blood before and after LPS-activation [109]. However, 
plasmablasts were found in the trout blood in two previous studies [8, 108]. Both studies 
looked at total immune cell populations. Bromage et al [8] looked at total cell 
proliferation in the blood using hydroxyurea (HU), while Zwollo et al [108] looked at 
percoll-purified cells.
The data from this study disagree with the blood proliferation data presented by 
Bromage et al [8] and Zwollo et al [108]. In the current study, we found few to no 
plasmablasts in the blood during the 10-day LPS-activation period. This study used BrdU 
incorporation in combination with the B cell-specific markers Membrane IgM, Secreted 
IgM, and Pax-5 to identify proliferating B cells in a heterogeneous mixture of immune 
cells. It is possible that there were too few plasmablasts/proliferating cells present in the 
blood to be detected with this method. It is also possible that, as discussed above, the 
blood cells may be dying in culture due to LPS-activation or lack of cytokines necessary 
for survival. In order to determine if there are proliferating B cells present in the blood, 
future studies with BrdU incorporation need to be conducted. Apoptosis studies should 
also be considered to determine if the blood B cells are dying before they are able to
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proliferate, which would help to explain the lack of plasmablasts and the few plasma cells 
seen in this tissue.
4.3. The anterior kidney contains a low number of LPS-responsive mature B cells.
The anterior kidney of the rainbow trout is a complex organ with a heterogeneous 
immune cell population. As the primary site of hematopoiesis, the anterior kidney is 
expected to contain early developing B cells. Studies have reported that a population of 
ASCs exists in the anterior kidney as well [8, 108, 109]. Developing B cells are 
insensitive to LPS-activation. Therefore, if the majority of B cells in the anterior kidney 
are developing B cells, then there will be little to no change in the population after LPS- 
activation.
It has been well documented that RAG-1 is expressed in developing B cells in 
mammalian bone marrow [67, 87] and as the site for B cell development we expect to see 
RAG-1 expressing cells in the anterior kidney of the rainbow trout. RAG-1 expression 
has been documented in the anterior kidney of both the zebrafish (Danio rerio) [103] and 
the carp (Cyprinus carpio) [40], suggesting that developing B cells are present in the 
anterior kidney of these fish. Developing B cells have not been investigated or well 
defined in the trout immune tissues. Future experiments using two-color flow cytometry 
with RAG-1 and other early B cell markers such as Pax-5, EBF, and Ikaros, would 
provide insight into the developing B cell populations in the trout anterior kidney.
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In this study, as well as in previous work from our lab [109], it was found that the 
anterior kidney contains very few resting, mature B cells. This would be in agreement 
with the anterior kidney containing mostly developing B cells, as discussed above. 
Resting, mature B cells (IgM+) are classified as Pax-5+/Membrane IgM+/Secreted 
IgM-/Total IgM+/Xbp-l+/-. Through flow cytometric analyses, we found 1%< resting B 
cells in the anterior kidney, based on this phenotype. The previous study from our lab 
analyzed purified Membrane IgM+ B cell populations from the anterior kidney, finding 
no resting, mature B cells [109].
It has been proposed that as the developing B cells in the anterior kidney reach 
maturity, they leave the anterior kidney for the posterior kidney or the blood and 
eventually travel to the spleen ([108], also see Figure 4 in Chapter 1). The results from 
this thesis research support this hypothesis in that few resting B cells are found in the 
anterior kidney while the posterior kidney, blood, and spleen contain high numbers of 
resting, mature B cells.
4.4. Unexpected low levels of Pax-5 expression in B cells of the anterior and 
posterior kidney.
In mammals, Pax-5 is expressed from the pre-B cell through plasmablast stages, 
where levels begin to decrease after activation [1]. Surprisingly, in the trout kidney, we 
observed very low levels of Pax-5 expression, which was also observed in earlier RT- 
PCR experiments from our lab [109]. We hypothesize that the anterior kidney B
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lymphocyte population consists mainly of developing B cells, while the B lymphocyte 
population in the posterior kidney would contain mostly resting and activated B cells. If 
this were the case, we would expect to see higher levels of Pax-5 expression in both 
regions of the kidney.
The low levels of Pax-5 expression in the trout kidney may be due to alternative 
splicing. Work done in our lab has found extensive alternative splicing of Pax-5 in the 
trout, with different isoforms present depending on the developmental and activation state 
of the B cells (P. Zwollo and R. Talauliker, data not shown). If alternative isoforms of 
Pax-5 are present in the kidney after activation, then our Pax-5 (ED-1) paired-domain 
antibody may not bind to the isoforms, leaving their presence undetected. Further 
investigation with antibodies directed against the Pax-5 isoforms found in the kidney is 
necessary to understand the Pax-5 expression patterns in the trout anterior and posterior 
kidney.
4.5. A population of Pax-5+, Membrane IgM - cells suggests the presence of IgD+ or 
IgT+ B cells in the spleen and blood.
A previous study from our lab, which used density gradients to separate B cell 
populations, found that the majority of the freshly isolated spleen cells were present in 
the high-density P70 layer (resting B cells), while very few cells were present in the 
intermediate density P60 (activated B cells or early plasmablasts) or low-density P50 
(late plasmablasts or plasma cells) layers [108]. Much like the spleen, prior to LPS-
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activation, the majority of blood B cells are present in the P70 layer [108]. In agreement 
with the percoll-density study, flow cytometric and qPCR data from our lab have shown 
that freshly isolated B cells from the spleen are mostly in a resting state [109]. This work 
has found the majority of freshly isolated B cells from the spleen, as well as the blood, 
are resting B cells, characterized as Pax-5+, Membrane IgM+.
After LPS-activation, the frequency of the resting B cell population decreases in 
both the spleen and the blood. We saw variation in the number of Pax-5+, Membrane 
IgM+ resting B cells in our experiments, but this population consistently decreases over 
the 10-day LPS-activation period in all experiments. This correlates with previous 
findings that B cells lose their Pax-5 and Membrane IgM expression after LPS-activation 
[109].
Interestingly, a portion of these resting B cells is characterized as Pax-5+, 
Membrane IgM - through flow cytometric analyses, suggesting that these cells may be 
IgD+, IgT+, or, less likely, pro-B cells. In the previous study [109], this population of 
resting B cells, characterized as Pax-5+, Total IgM- was highest in frequency on Day 0 
and then decreased after LPS-activation, in agreement with the data from the current 
study. Freshly isolated blood B cells show a similar population of Pax-5+, Membrane 
IgM - cells that decrease in frequency after Day 2 of the LPS-activation period. In both 
the spleen and the blood, the cells are most likely resting IgD+ or IgT+ cells that become 
activated B cells after stimulation. Future studies with IgD or IgT antibodies, when they
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become available, are necessary to determine if the Pax-5+, Membrane IgM- population 
consists of resting B cells of a different Ig isoform or if they are pro-B cells.
In the blood, it is likely that the Pax-5+, Membrane IgM- cells become activated 
B cells after LPS-stimulation. However, it is possible that these resting B cells may 
undergo cell death in culture. As this research and previous work has shown, the blood 
contains very few plasmablasts and plasma cells, suggesting that the B cells in this tissue 
do not progress past the activation stage [108, 109]. We see a large portion of the blood B 
cell population die during the culture period (data not shown). The cells may undergo 
apoptosis due to LPS-activation or due to lack of cytokines necessary to sustain the B 
cells in culture. The lack of plasmablasts and low levels of IgM secretion suggest that the 
blood B cells are dying after LPS-activation.
The combination of Pax-5 and Membrane IgM markers, when analyzed by two- 
color flow cytometry, provide information about the activation state of B cells as we 
characterize resting B cells as Pax-5+, Membrane IgM+, activated B cells as Pax-5+, 
Membrane IgM++, plasmablasts as Pax-5+/-, Membrane IgM+, and plasma cells as Pax- 
5-, Membrane IgM-. The changes in the expression levels of Pax-5 and Membrane IgM 
correlate with the progression through the later B cell stages where we see Pax-5 and 
Membrane IgM expression decrease as the cells differentiate into plasma cells.
The information provided by the Pax-5 and Membrane IgM expression patterns 
may help to assess the health of fish. In teleosts, the spleen becomes enlarged during an
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infection, providing an indicator as to the immune state of the fish. Analyzing splenic B 
cells through flow cytometry may provide a tool to determine immune activation prior to 
the enlargement of the spleen. The data provided by the Pax-5 and Membrane IgM 
markers in this study show that, by looking at the relative levels of Pax-5 low 
(+/-)/Membrane IgM+ cells, Pax-5+/Membrane IgM+ cells, and Pax-5+/Membrane 
IgM - cells in freshly isolated spleen cells, the activation state of the fish immune system 
could be assessed.
4.6. A novel Pax-5 low (+/-), Membrane IgM+ B cell population is found in the 
spleen.
The co-expression of Pax-5 and Membrane IgM, as analyzed by flow cytometry, 
identifies populations of either resting B cells or activated B cells/plasmablasts, within a 
cell population. A population of Pax-5 low (+/-), Membrane IgM+ cells was found in 
freshly isolated and LPS-activated spleen cells. There was variation as to the frequency of 
this population between three independent experiments. The B cell stage of these Pax-5 
low, Membrane IgM+ cells is not clear. These cells may be activated B cells that are 
already decreasing their Pax-5 expression levels. In mammals, Pax-5 is expressed from 
the pre-B cell through mature B cell stages and activated B cells begin to lose their Pax-5 
expression [1]. As a site of B cell activation, we expect to see lower levels of Pax-5 
expression in splenic B cells. This novel population, found exclusively in the spleen, 
suggests that splenic B cells may become activated faster than B cells in the blood or 
kidney, if these cells are indeed activated B cells.
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It is possible that our Pax-5 (ED-1) antibody is not binding all of the Pax-5 
expressed in the spleen. Our lab has found extensive alternative splicing of Pax-5 in the 
spleen (data not shown), which could explain the presence of B cells (Membrane IgM+) 
with little to no Pax-5 expression. These cells may be expressing higher levels of Pax-5, 
making them resting B cells instead of activated B cells. This is why it is unclear at this 
point what type of B cells these Pax-5 low (+/-), Membrane IgM+ cells are and future 
experiments with Pax-5 antibodies that recognize the alternatively spliced isoforms are 
necessary.
4.7. LPS-induction of a RAG-1+, IgM-secreting B cell population in the spleen and 
blood.
The Recombination Activating Genes (RAG-1 and RAG-2) are expressed in pro- 
and pre-B cells as the Ig genes undergo V(D)J recombination [29, 67, 87]. Low levels of 
RAG expression have also been found in immature, resting B cells, but as membrane IgM 
levels decrease in these cells, RAG expression decreases [106]. RAG expression has 
been documented in peripheral lymphoid organs after antigenic stimulation, suggesting 
that mature B cells also express RAG [37, 69]. It has also been shown that immature B 
cells expressing RAG travel to the spleen after antigenic stimulation, accounting for the 
RAG expression seen in peripheral organs [61]. In this thesis research, RAG-1 was used 
in combination with Secreted IgM in order to distinguish between developing B cells and 
activated B cells.
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Flow cytometric analysis of RAG-1 and Secreted IgM staining revealed 
interesting expression patterns in both the spleen and the blood. Surprisingly, there is 
induction of a RAG-1 expressing, IgM secreting B cell population after LPS-activation in 
both tissues. There is variation between experiments in the number of cells with this 
phenotype, but this population increases in both RAG-1 and Secreted IgM levels over the 
10-day culture period. This population most likely consists of activated B cells or 
plasmablasts. As this study was conducted ex vivo and the spleen and blood are 
secondary immune organs, it is likely that we are seeing expression of RAG-1 in mature, 
activated B cells, in agreement with mammalian studies [37, 69]. The re-expression of 
RAG-1 in these cells may accompany class switch recombination after activation in these 
cells. It has been shown that in addition to IgM, trout B cells produce IgT and IgD ([32, 
104], respectively). The re-expression of RAG-1 in the activated B cells/ASCs of the 
spleen and blood suggests that these cells are undergoing the process of class-switch 
recombination. At this point there are no antibodies available for trout IgD or IgT, but 
future work with these antibodies and PCR would provide information on class-switch 
recombination in these cells.
4.8. Conclusions, significance, and future work.
The data from this thesis work provide information on the development, 
activation, proliferation, and differentiation of B cells in trout immune tissues. Previous 
work from our lab has looked at these processes in purified B cell populations [108, 109],
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while this study analyzed individual cells from trout spleen, blood, and kidney ex vivo. 
The flow cytometric analyses in this thesis research expand upon the knowledge of the B 
cell populations present in trout immune tissues through the use of multiple B cell 
markers measured in individual cells. This method allows us, for the first time, to obtain 
information on the frequencies of the various B cell populations present in trout immune 
tissues.
As the demand for fish as a food source makes aquaculture an increasing 
necessity, the need to understand the teleost immune system becomes an important focus 
for immunologists. Grown in close proximity to one another, farm-raised fish, especially 
at the juvenile stage, are highly susceptible to disease and infection. There is an 
increasing need for vaccines for farm-raised fish; however, the immune system of teleosts 
is poorly understood, making vaccine development difficult. Identifying sites of B cell 
activation and antibody secretion can provide target sites for vaccines.
The method and markers used in this project provide preliminary information for 
the future use of flow cytometry as a diagnostic tool for evaluating immune system 
activation. As technology continues to evolve, flow cytometry will become more 
economical and accessible, providing a practical machine to use when analyzing not only 
fish, but vertebrate health. B cells and their transcription factors have been extensively 
studied in the mammalian immune system, but little is known about the teleost immune 
system. The data presented here provide insight into the activation state of B cells in the 
trout by analyzing B cell marker combinations before and after LPS-activation. The
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changes in the expression patterns of the B cell populations can provide markers as to the 
activation state of the trout immune system and provide information on trout health. 
These markers and methods, however, have the potential to be used in monitoring 
immune responses in all vertebrates, as the same cell types and markers are found in 
mammals and teleosts.
Further investigation of the B cells within trout immune tissues is necessary to 
better understand the processes of B cell development, activation, and differentiation. 
Studies with apoptosis markers are necessary to determine the cell death rates in the 
blood and spleen and experiments with early B cell markers are necessary to identify the 
B cell populations present in the anterior kidney. As additional B cell markers are 
developed and tested, future studies can provide further information about the complex B 
cell populations present in the immune tissues of rainbow trout and other teleosts, both 
before and after antigenic stimulation. Eventually, flow cytometry may be used to 
determine vaccine efficiency in immunized fish. Or perhaps, as mentioned previously, 
specific B cell marker combinations could be analyzed using flow cytometry to determine 
the immune state of a fish. This method has the potential to not only monitor fish health, 
but could possibly identify an infection or immune reaction prior to a visible sign. This 
thesis work provided a starting point for further investigation of the B cell populations 
present in the trout immune system. Future studies will continue to provide information 
on the functioning of the teleost immune system and lead to the development of vaccines 
and treatments to protect these important aquaculture species.
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